Petition — SCM Corp. v. Xerox Corp.

Supreme Court brief1982

Ask Donna

What actually matters in this document.

Text

80-2092

+ oe

IN THE

Supreme Court of the United States revas

OCTOBER TERM, 1980

JUN 10 1981

>

SCM CORPORATION,

Petitioner,

XEROX CORPORATION.

PETITION FOR A WRIT OF CERTIORARI

TO THE UNITED STATES COURT OF APPEALS

FOR THE SECOND CIRCUIT

Of Counsel:

IRA B. GRUDBERG

Davip L. BELT

Jacobs, Jacobs & Grudberg, PC.

350 Orange Street

New Haven, Conn. 06503

JEROME GOTKIN

W. THOMAS FAGAN

Widett, Siater & Goldman, PC.

60 State Street

Boston, Mass. 02109

June 10, 1981

GORDON B. SPIVACK

25 Broadway

New York, N.Y. 10004

(212) 344-8480

Attorney for Petitioner

DAVID H. MARKS

JONATHAN M. JACOBSON

Lord, Day & Lord

25 Broadway

New York, N.Y. 10004

BERNARD J. NUSSBAUM

HAROLD C. HIRSHMAN

Sonnenschein Carlin

Nath & Rosenthal

Suite 8000 Sears Tower

233 South Wacker Drive

Chicago, II]. 60606

itn Oe

Office-Supreme Court. U.S |

QUESTIONS PRESENTED

1. Are purchases of patents exempt from application of the

antitrust laws, by reason of patent law policy, solely

because they are made prior to the emergence of a relevant

product market embodying the patented inventions—even

where (i) hundreds of patents and patent applications are

purchased; (ii) the purchaser is already licensed to practice

the patented inventions; (iii) the purchases are not reasona-

bly necessary to induce continued commercialization of the

patented inventions by the purchaser; (iv) absent the pur-

chases there would have been competition as a result of

sublicenses granted by the patent owner; and (v) the

foreseeable and actual result of the purchases is a persist-

ent, substantial economic monopoly?

2. Are purchases of patents exempt, by reason of patent law

policy, from the rule that the legality of an acquisition

under the antitrust laws may be tested at the time its

anticompetitive effects occur—even where the purchaser

has excluded all competition by enforcing and refusing to

license the purchased patents, thus maintaining a persist-

ent, substantial economic monopoly?

Pursuant to Rule 28.1 of this Court, Petitioner SCM Corporation states

that it has no parent or affiliates; its subsidiaries (other than wholly-owned

subsidiaries) are: Allied/Egry Business Systems, Inc. (a subsidiary of Allied

Paper Incorporated); and Pinturas Ecuatorias, S.A., Distribuidora Ameri-

cana, C.A., Pinturas Centro-Americanas, S.A., Glidden de Honduras, S.A.,

Galvanizadora Centro-Americana, S.A., Compania Agricola Myristica, S.A.

and Pinturas Centro-Americanas Costa Rica, Ltda. (all subsidiaries of

SCM-Glidden International Co.).

TABLE OF CONTENTS

Page

QUBSTIONS PRESENTED ...cccccsccvcsccscccvess i

pe ER Ga Pty) ay rere iv

PP MEY odes becedacesedsndsddveeeseuns 1

RR rr ery et re 2

See EE bad cee ceeanenecnsedeecheens 2

PE Fecckssesiackeecebasucesseieusbaness 2

PES CE cu cbbineceesehaboseaeheusecue

PUD CUI sinc ca cenasvcetécssecsaedcaurtas 7

REASONS FOR GRANTING THE WRIT........... 10

I. In Creating an Exemption From the Antitrust

Laws by Reason of “the policies of the patent

laws,” the Court of Appeals Decided an Impor-

tant Question of Federal Law That Should Be

Us OE Ce SANS vnvcctccsnvecccsecsses 10

II. The Exemption Created by the Court of Appeals

Is Unwarrafited and Conflicts With Applicable

SPeGeeenee Ge Ce NN occ accdveeccecceessenes 13

A. The court of appeals’ decision conflicts with

applicable decisions of this Court governing

TION GHOURBTIORS 200 ccc cccccseccsonseas 13

B. The creation of an implied exemption is un-

necessary to further the policies of the patent

FRO ee EEE eee ee ee 15

iii

Page

C. There is no basis for a distinction between

patent purchases made prior to and those

made subsequent to the emergence of a rele-

vant market embodying the patented inven-

tion; and the distinction disregards the impact

on potential competition ...........60.00e 19

The Decision of the Court of Appeals Conflicts

With Applicable Decisions of This Court Holding

That the Legality of an Acquisition Under the

Antitrust Laws May Be Determined at the Time

Its Anticompetitive Effects Occur.............. 22

ec Bs PT eee ee TT rTeTTTreT rr eTer sree 26

APPENDICES:

A. Opinion of the Court of Appeals .............. la

B. Opinion of the District Court ................. 4la

C. Judgment of the District Court................ 127a

D. May 10, 1979, Opinion of the Court of Appeals . 129a

E. May 18, 1979, Opinion of the District Court .... 133a

F. May 25, 1979, Order of the Court of Appeals... 143a

G. Judgment of the Court of Appeals............. 145a

H. Order of the Court of Anpeals Denying Rehearing 147a

De: ME SUMO 2 snd dvcteeedcvcecweusa vines 149a

iv

TABLE OF AUTHORITIES

CASES: Page

American Tobacco Co. v. United States, 328 U.S. 781

ER err ere rT Tr rr rr errr ree rr 10n

Appalachian Coals, Inc. v. United States, 288 U.S. 344

PEP rer rrr errr rere Tre Te ree 23

B.B. Chemical Co. v. Ellis, 314 U.S. 495 (1942) ...... 12n,

14n, 21n

Berkey Photo, Inc. v. Eastman Kodak Co., 603 F.2d 263

(2d Cir. 1979), cert. denied, 444 U.S. 1093 (1980).... 24n

Broadcast Music, Inc. v. Columbia Broadcasting Sys-

wy eS FPR PeTTeRTTT TT riTTrer ; 17

California v. Federal Power Commission, 369 U.S. 482

DR SSCL SCLC SAMEGEMAS RAD ARUS TED SAOR END RESO TAS 14

California Retail Liquor Dealers Ass’n v. Midcal

Aluminum, Inc., 445 U.S. 97 (1980)............. 12n, 14n

Carnation Co. v. Pacific Westbound Conference, 383

SL NS onc ks dd cd Neb oe waedssee saw hanceeds 15n

City of Lafayette v. Louisiana Power & Light Co., 435

Es bane hb 4a knee Vawnds cadepeeen web ks 14n

Connell Construction Co. v. Plumbers Local 100, 421

RR OTT er Tree errr ere Ter err ree 15n

Dawson Chemical Co. v. Rohm & Haas Co., 448 U.S.

SE CaN Dic se ahdses esha vanweneee un es 12n, 16, 24n

Deepsouth Packing Co. v. Laitram Corp., 406 U.S. 518

| RRA ae eho re ee ye eae 14n

Diamond vy. Chakrabarty, 447 U.S. 303 (1980) ........ 13

Eastman Kodak Co. v. Southern Photo Materials Co.,

oy oe er cr ere 24n

FMC v. Seatrain Lines, Inc., 411 U.S. 726 (1973) ..... 14

Page

Goldfarb v. Virginia State Bar, 42i U.S. 773 (1975).... 14

Group Life & Health Insurance Co. v. Royal Drug Co.,

QEPUD. Be COD 6 v.cevevacsncescccdawsceneo 12n, 15n

Hanover Shoe, Inc. v. United Shoe Machinery Corp.,

See UES: GRD CHRD 6s vo ncndscenvesacsevastanee 24n

Hecht v. Pro-Football, Inc., 570 F.2d 982 (D.C. Cir.

1977), cert. denied, 436 U.S. 956 (1978)..........6. 24n

Kobe, Inc. v. Dempsey Pump Co., 198 F.2d 416 (10th

Cir.), cert. denied, 344 U.S. 837 (1952)..........4.. lin, 25

Lorain Journal Co. v. United States, 342 U.S. 143

COPED bcc cecececcccnssesnescccsnbeenaneneen 24n

Mannington Mills, Inc. v. Congoleum Industries, Inc.,

fe £ ct fe oer 18, 23-24n

Moraine Products v. ICI America, Inc., 538 F.2d 134

(7th Cir.), cert. denied, 429 U.S. 941 (1976)......... 18

Motion Picture Patents Co. v. Universal Film Mfg. Co.,

BOD US. FEB CIT 6 cncccasccccsesscccctasadasua 12n

National Broiler Marketing Ass’n v. United States, 436

RE, BOG CIID cin wcccacedessensscaesssncawexnnne 12n

National Gerimedical Hospital & Gerontology Center v.

Blue Cross of Kansas City, No. 80-802 (argued April

, B. | PeerererrTeTrerrrrrrrrrr rrr rr co 12n

National Society of Professional Engineers v. United

Shates, 435 U.S. G79 GADD oc ccccvccsvcssscececous 10, 20

Otter Tail Power Co. v. United States, 410 U.S. 366

CPT a 6k 0 ik nb 609 skeseceesseeeeesnsecauen 15, 15n, 24n

Silver v. New York Stock Exchange, 373 U.S. 341 (1963) = 14,

35, 17

Standard Oil Co. v. United States, 221 U.S. 1 (1911) 10n, 17

vi

Page

Standard Sanitary Mfg. Co. v. United States, 226 U.S.

DULG i Cel Lana ceN skated bescessessceseess 14

Transparent-Wrap Machine Corp. v. Stokes & Smith

Se Mies PE CODED 60 kdb sscesbsescdvecees 12, 12n

United States v. Addyston Pipe & Steel Co., 85 F. 271

(6th Cir. 1898), aff'd as modified, 175 U.S. 211 (1899) —s:18

United States v. Aluminum Co. of America, 148 F.2d

Ee csc pckeev ea ebebb eres 10n, 11, 16

United States v. Besser Mfg. Co., 96 F. Supp. 304 (E.D.

Mich. i951), aff'd, 343 U.S. 444 (1952)............ lin

United States v. Borden Co., 308 U.S. 188 (1939) ..... 14, 17

United States v. Citizens & Southern National Bank, 422

Ee ee 23n

United States v. E.I. duPont de Nemours & Co., 353

ese las ake eeake ee aeaeeee a 9, 11, 22-25

United States v. Griffith, 334 U.S. 100 (1948)........ 10n, 11

United States v. Grinnell Corp., 384 U.S. 563 (1966)... = 21

United States v. ITT Continental Baking Co., 420 U.S.

cael seen span a 6b 0b6 Rhee eee ee 22

United States v. Jerrold Electronics Corp., 187 F. Supp.

545 (E.D. Pa. 1960), aff’d per curiam, 365 U.S. 567

ACE StGtC as UAbEcatanedteNesuebesdendnesee 23n

United States v. Line Material Co., 333 U.S. 287 (1948) 14n

United States v. Masonite Corp., 316 U.S. 265 (1942).. 14n

United States v. Penn-Olin Chemical Co., 378 U.S. 158

SEGMENTS phat RS ae 22

United States v. Philadelphia National Bank, 374 U.S.

te Lbs eee seuceviakeshsnabedins sx 14, 21

United States v. Singer Mfg. Co., 374 U.S. 174 (1963) 14n

Vii

Page

United States v. Southern Pacific Co., 259 U.S. 214

SE 65.550 ke 04s ON eb VARETS hae hae SSL ERAN chReR 11, 23

United States v. Terminal Railroad Ass’n, 224 U.S. 383

EE NADAS GREER ESAWSE SEES SALNG DONE UDR ORORe CSS 24n

United States v. Topco Associates, 405 U.S. 596 (1972). 14n

United States v. United Shoe Machinery Corp., 110 F.

Supp. 295 (D. Mass. 1953), aff’d per curiam, 347 U.S.

De PE 5.5455 60s0SeseeSy A aN becnenbesedeness 1Ca

United States v. United States Gypsum Co., 333 U.S.

Co reer Te er rer Terr reer Te CLE 17

Waiker Process Equipment, Inc. v. Food Machinery &

Chemicul Corp., 382 U.S. 172 (1965) .......0eeeeee 12n

Zenith Radio Corp. v. Hazeltine Research, Inc., 395

be fi SPerrerr rr eer eer err er erie 2in, 24n, 25

CONSTITUTION AND STATUTES:

8 Ge ae ee Se SP rrerrer ee rr 15-16

Sherman Act:

Be Or ie OR os esa ea ed ececonkeceweress passim

| wm Be 8 ot & rere rererrrerrirr rer passim

Clayton Act:

EOD Do Ba Siete DE paccacocccccsscsstesacse 8n

ees BBS Gas OS OP ceccctcccecectvescesovess , ee

Oeteee FT, TS UB, BG csc ccvccsccccsvaccecens passim

BE es ED aoa cacseanrehscsuanaedeweweanen 2

SR a Ce os onc baneedkdede des ebae\eanns see 7

ee ab cn kc cd PRGRe) OSes tee eaberae wee es 16

BP Ses Ee waice cockends cédcebeieseeressedes 18n

ee Ec oo ctuncebcvawbesteses\ 6040 Kanne 18n

42 U.S.C. § 7608 2... crccccccccccvvccvesscvesevees 18n

viii

OTHER AUTHORITIES:

R. NORDHAUS, PATENT-ANTITRUST LAW (1980)....... 21

F.M. SCHERER, THE ECONOMIC EFFECTS OF COM-

PULSORY PATENT LICENSING (NYU Bus. Admin.

PODMORIUED CAPT Ei occ cc vocccscuacvcssbausaveccs 15

Stedman, The Patent-Antitrust Interface, 58 J. PAT. OFF.

BOG YN FOR CHP OU s vccnuvkbvsgethbeseavewnes ears 15

DEPARTMENT OF JUSTICE, ANTITRUST GUIDE CON-

CERNING RESEARCH JOINT VENTURES (1980). ..16, 18, 18n

Hearings on S. 390 Before the Subcomm. on Antitrust

and Monopoly of the Senate Comm. on the Judiciary,

fe eG reer ee 22n

IN THE

Supreme Court of the United States

OCTOBER TERM, 1980

No. ___

>

SCM CORPORATION,

Petitioner,

XEROX CORPORATION.

>

PETITION FOR A WRIT OF CERTIORARI

TO THE UNITED STATES COURT OF APPEALS

FOR THE SECOND CIRCUIT

SCM Corporation respectfully prays for a writ of certiorari

to review the judgment of the United States Court of Appeals

for the Second Circuit in this case, entered on March 12, 1981.

OPINIONS BELOW

The opinion of the United States Court of Appeals for the

Second Circuit (Appendix A, PA la-40a) is not yet officially

reported.' The opinion of the United States District Court for

the District of Connecticut (Appendix B, PA 4la-126a) is

reported at 463 F. Supp. 983.

! The citation “PA ___” refers to the appendix to this petition. The

citations “A ___,” “SA ___” and “E ___” refer to the Joint Appendix in

the court below, a copy of which, together with the parties’ briefs, has been

lodged with the clerk of this Court.

2

JURISDICTION

The judgment of the court of appeals was entered on March

12, 1981. (PA 145a). This Court’s jurisdiction is invoked under

28 U.S.C. § 1254(1).2

STATUTES INVOLVED

Sections 1 and 2 of the Sherman Act, 15 U.S.C. §§ 1, 2, and

Sections 4 and 7 of the Clayton Act, 15 U.S.C. §§ 15, 18, are

set forth in the appendix. (Appendix I, PA 149a-Sla).

STATEMENT

This case involves the monopolization of a major industry

and the exclusion of Petitioner SCM Corporation from the

monopolized market. It is undisputed that, by 1969, Xerox

Corporation had monopoly power in the convenience office

copying market and the plain paper copying submarket. (PA

117a-18a). From 1960 to 1970, Xerox was the only company

marketing plain paper copiers in the United States. (PA 4a). As

late as 1975, Xerox’s share of the plain paper copying market

was 83.7 percent. (E 3797).

Xerox’s monopoly was not based on internally developed

technology. It was based on Xerox’s purchase of hundreds of

patents and patent applications from Battelle Memorial Insti-

tute, at a time when Xerox was already licensed to practice the

patented inventions, when the purchases were unnecessary to

induce Xerox to continue commercializing the inventions, and

when the forseeable result of the purchases was that Xerox

would obtain an economic monopoly. Had Xerox not pur-

chased the patents, Battelle would have granted sublicenses,

ensuring competition in plain paper copying. Instead, by en-

forcing and refusing to license the patents it had purchased,

Xerox was able to maintain a persistent, substantial economic

monopoly.

2 A petition for rehearing, relating to an SCM claim for damages that is not

before this Court, was filed on March 25, 1981, and was denied on June 3,

1981. (PA 37a-40a, 147a-48a).

Statement of Facts

Xerography, the patented process on which plain paper

copying is based, was invented by Chester Carlson in 1937. (PA

4a; A 734-36; E 2867). In 1944, Carlson assigned his patent

rights (and later the patents themselves) to Battelle Memorial

Institute, a non-profit research foundation.’ By 1947, Battelle

had developed the process to the point of commercial feasibil-

ity, generating numerous crucial secondary patents along the

way. (PA Sa; A 792; E 211-18, 316-17, 1251, 1254, 1267, 1486).

It was then that Xerox, at that time called The Haloid Com-

pany, became involved. Originally seeking a license that would

be exclusive for a limited period of three to seven years

following commercialization, in 1947 Xerox instead accepted

the non-exclusive license offered by Battelle. (E 175, 182).

Battelle wanted to preclude a monopoly by Xerox of the

xerographic process. (E 208). Accordingly, in 1948, while

agreeing to allow Xerox’s non-exclusive license to be made

“exclusive,” Battelle required Xerox to seek sublicensees, and

Battelle retained the right to compel Xerox to sublicense.

Xerox accepted the license under these conditions. Under this

1948 license agreement, Xerox was also required to assign to

Battelle any xerographic patents Xerox might obtain. (PA

6a-7a, 31a-32a; A 3577-78, 3585, 3592-94; E 475-78, 496).

By the early 1950’s, Battelle had made additional improve-

ments in the xerographic process that enabled Xerox to market

two xerographic products successfully—the “Copyflo,” which

xerographically printed plain paper copies from microfilm

rolls, and the “Flat Plate Equipment,” which xerographically

prepared plain paper copies and masters for offset copying. By

1956, Xerox was deriving 40 percent of its profits from those

two products. (PA 7a; A 891-93, 2541-43; E 316, 1281-83). The

mechanical elements for a xerographic convenience office cop-

ier were available in 1953, and by 1954, Xerox and Battelle

knew enough to build a commercially viable plain paper copier.

(E 808-09, 1269; PA 7a).

3 Title to the patents was held by Battelle Development Corporation, a

wholly-owned subsidiary of Battelle Memorial Institute.

4

By the mid-1950’s, there was a substantial and growing

business in coated paper convenience office copiers using

processes other than xerography. (E 1677-78, 1771; PA 7a).4

But the xerographic plain paper copying process developed by

Battelle was vastly superior to any of the coated paper proc-

esses. As early as 1953, Xerox believed that “these xerography

inventions [were] so basic and so numerous as to present a

‘once in a lifetime’ opportunity to grasp and maintain domi-

nance uf a vigorous and potentially great new industry.” (E

2339-40, 2762). Plain paper copying offered such certain pros-

pects for success that, by 1953, Xerox valued a non-exclusive

xerographic patent sublicense at $70 million. (PA 7a).

Thus, by 1956, it was reasonably foreseeable that plain

paper copying would develop into its own relevant product

market; and Xerox realized that, if it could purchase the

patents from Battelle and eliminate its sublicensing obligation,

it would have a monopoly—of both the plain paper copying

market and the broader convenience office copying market

(i.e., plain and coated paper office copiers). (PA 7a, 26a,

29a-30a).

That was the context in which Xerox sought and obtained a

new agreement with Battelle—the “1956 Agreement”—that

gave it the power to exclude all competition from plain paper

copying. The 1956 Agreement (1) eliminated Xerox’s obliga-

tion to sublicense and Battelle’s power to compel sublicensing;

(2) gave Xerox immediate title to the four original Carlson

patents (the last of which was to expire in 1961); (3) gave

Xerox an exclusive license through December 31, 1958 on each

of the hundreds of other Battelle patents and patent applica-

tions relating to xerography; (4) gave Xerox the right to

acquire title to those patents and patent applications in 1959;

(5) extinguished Xerox’s obligation to assign to Battelle any

xerographic patents it might obtain; and (6) committed Battelle

to assign all of its future xerographic patents and know-how to

Xerox and to work exclusively for Xerox so long as Xerox

4 The new coated paper convenience office copiers that emerged in the

1950’s included machines from Kodak, 3M and Apeco. (PA 7a-8a). By 1958,

annual sales of coated paper copiers reached $175-200 million. (E 1677).

5

contributed $25,000 in xerographic research funds annually.

(PA 8a-9a; E 334-42).

The 1956 Agreement effected a basic structural change in the

industry: but for the agreement, Battelle would have compelled

sublicensing of the xerographic patents and there would have

been competition—instead of monopoly—in plain paper copy-

ing. (PA 8a, 3Ja, 123a; A 870-72, 4575-77; E 208).

In 1959, pursuant to the executory provisions of the 1956

Agreement, Xerox exercised its right to purchase the 318

existing Battelle patents and 327 patent applications. (PA 9a; A

942-44). In 1960, Xerox purchased from Horizons, Inc., a

contract research firm, the only significant xerographic patents

it did not already own. (A 2793-98; E 769-80). That same year,

Xerox introduced the first plain paper copier, the 914.

Entry into plain paper copying by other companies was

impossible. No one could invent around the patents Xerox had

purchased. Many companies tried, including IBM, which alone

spent $42.8 million in its unsuccessful attempt. (A 1400-02).

During the 1960’s, a number of companies, although denied

entry into plain paper copying, marketed coated paper copiers.

By the mid-1960’s, Petitioner SCM had become the leading

company in the coated paper copying field. (E 1535, 1571,

2824-29).5 Customers had a definite preference for plain paper

copiers, however, because coated paper copies tended to

smudge, crack, smear, fade and sweat; they emitted an odor,

were heavy, difficult to write on, and had a slick feel. (E 1120,

1858-59, 1870). By the late 1960’s, it became impossible to

compete effectively with coated paper alone. (E 1558, 1870). In

the 1970’s, the coated paper copying business was marked by

losses, failures and bankruptcies. (E 2673-74, 3792-94; A

2467-75).

Consumers also suffered from Xerox’s monopolistic control

of plain paper copying. Production was restricted and demand

5 Xerox had no interest in coated paper copying and licensed patents to

other companies, including SCM, with a field of use restriction to coated

paper use only. (A 1191).

6

left unsatisfied. Xerox conceded that, as late as 1969, the

market opportunity for plain paper copiers greatly exceeded

Xerox’s machine population. (A 1302-03; see also E 1672; A

2395-430). Although it used only a small fraction of the

technology it controlled (E 1176, 2678; A 1040), Xerox denied

to others the opportunity to develop unused alternative ap-

proaches to plain paper copying, such as “TESI” and “xero-

printing,” both of which were Battelle inventions purchased by

Xerox (A 836-41, 2076-85; E 799-800). Innovative features,

such as reduction capability and push-button control of paper

length, were not available in Xerox’s copiers until long after

their introduction by coated paper firms. (E 3336-41, 1630-32,

1857, 1872, 2801; see also E 1590-658). Xerox’s products were

poorly designed and unreliable. (E 365-66, 387, 392-93, 1117,

1690-92; A 1540-41). As one of Xerox’s top executives admit-

ted, “[Xerox’s] design skills were not the best,” but “[bJecause

[Xerox] had this patent protection, any mistake went.” (E

1273).

Because of Xerox’s monopoly, if consumers wanted conven-

ient plain paper copies, “they had to use a Xerox machine,

even if their overall satisfaction with Xerox performance was

marginal.” (E 1117). Therefore, Xerox was able to charge

exorbitant prices—as late as 1972 obtaining a 40-100 percent

premium over coated paper companies even under its “dis-

count” prices for large accounts. (E 1158; see also E 1060,

1239, 1924; : 1256, 1465-66). Xerox also was able to refuse to

sell its plain paper copiers and then to set sales prices, when

finally established, so high as to discourage sales almost

entirely, thus preventing its customers from getting “off the

hook” of Xerox’s highly profitable rental plans, and preclud-

ing others from entering the market by dealing in Xerox

copiers. (E 2770; see also E 81, 1087, 1101, 1709, 1933-34,

2975; A 1554-64, 2425-26). Xerox’s high prices led to enor-

mous profits. From 1960 to 1970, while Xerox was the only

company marketing plain paper copiers in the United States

(PA 4a), its annual gross profits increased from $6 million to

$400 million. By 1975, Xerox’s gross profits exceeded $800

7

million on $4 billion of revenue. (PA 10a). Between 1960 and

1975, Xerox’s gross profits totalled more than $4.8 billion, at

profit margins as high as 80 percent. (E 1231, 2665, 2770,

18-19; A 2173-77, 4203-05).

Xerox believed as early as 1964 that, eventually, the antitrust

laws would require that it license the patents it had purchased.

But Xerox decided to delay licensing as long as possible, “even

up to the point . . . of playing the game of Brinksmanship in

this connection.” (A 1360-67; PA 67a). Thus Xerox consis-

tently denied plain paper patent licenses to everyone. And

when other companies, beginning with IBM in 1970, intro-

duced infringing plain paper copiers, Xerox sued them for

patent infringement. (PA 58a).

SCM spent millions of dollars trying to invent around the

patents Xerox had purchased, but without success. (A 1515-

17). And SCM requested a plain paper copying license from

Xerox every year from 1963 through 1969 and beyond. Its

requests were repeatedly refused. (PA 10a-lla; A 1374-79,

1650-52; E 2680). In 1974, SCM commenced marketing a plain

paper copier. It was sued by Xerox for infringement. (A

2105-08).

Proceedings Below

SCM filed its complaint on July 31, 1973, seeking damages

and equitable relief for antitrust violations. Jurisdiction was

based on 15 U.S.C. § 15 and 28 U.S.C. § 1337. A preliminary

injunction was denied, 1974 Trade Cas. { 75,086 (D. Conn.),

aff'd, 507 F.2d 358 (2d Cir. 1974), and, from June 1977 to

August 1978, the case was tried to a jury—demanded by

Xerox. SCM asserted five claims, only one of which, SCM’s

“1969 exclusion claim,” is in issue here.®

On the 1969 exclusion claim, SCM sought to recover the

damages it suffered by reason of Xerox’s exclusion of SCM

6 Although the record in the trial court was lengthy, almost the entire

record was devoted to issues not before this Court—such as market defini-

tion, market power, causation, damages and SCM’s other claims.

8

from plain paper copying beginning in 1969. SCM contended

that it was commercially feasible to manufacture a plain paper

copier prior to the 1956 Agreement; that, absent the agree-

ment, Xerox would have made and marketed plain paper

copiers under its prior patent license from Battelle; that it was

foreseeable that the agreement would allow Xerox to monopo-

lize a major market; that Xerox in fact monopolized the

convenience office copying and plain paper copying markets

by, among other things, refusing to license the patents it had

purchased; and that, had it not been for the 1956 Agreement,

Battelle would have compelled sublicensing of the xerographic

patents to SCM, among others, by 1969. SCM urged that, on

these facts, Xerox had violated Sections 1 and 2 of the

Sherman Act and Section 7 of the Clayton Act.

The jury, responding to 52 interrogatories during its 38 days

of deliberation, found for SCM on the 1969 exclusion claim.

(PA 47a-49a, 112a-26a). The jury concluded that, by 1969,

Xerox had monopoly power in both the convenience office

copying market and plain pape: copying submarket; that

Xerox had wilfully acquired or maintained its monopoly

power, as a result, among other things, of the 1956 Agreement,

in violation of Section 2 of the Sherman Act; and that the 1956

Agreement was an unreasonable restraint of trade, in violation

of Section 1 of the Sherman Act, and an anticompetitive

acquisition, in violation of Section 7 of the Clayton Act, both

in 1956, when the agreement was made, and in 1969. (PA

113a-15a, 12la-22a).’? The jury found that Xerox had unlaw-

7 The jury’s finding of wilful acquisition or maintenance of monopoly

power was not limited to the 1956 Agreement and Xerox’s refusal to license

the patents it had purchased (PA 14a n.7), but was based on a course of

anticompetitive conduct that included: the subsequent purchase of important

patents from Horizons, Inc., grant-backs of exclusive copier rights in its

non-copier patent licenses, a conspiracy with its foreign affiliates (Rank

Xerox and Fuji Xerox) to divide world markets, a lease-only policy that

precluded development of competition in a secondary market for Xerox

copiers, employee covenants not to compete that enabled Xerox to have

control of 95 percent of the world’s xerographers as late as 1972, and an

unlawful pricing plan—MUP—that coerced some Xerox high volume ma-

chine customers into taking Xerox’s low volume machines. The jury made

specific findings that MUP violated Section 2 of the Sherman Act and

Section 3 of the Clayton Act. (PA 37a, 86a-87a, 120a, 124a-25a; E 109).

9

fully excluded SCM from plain paper copying from 1969 to

1976, and awarded damages, before trebling, of $37.1 million.

(PA 125a-26a).

The district court, without setting aside any of the jury’s

verdicts, directed entry of judgment in favor of Xerox on

SCM’s claim for damages. The court ruled that, even if

Xerox’s conduct violated the antitrust laws, the policies of the

patent laws precluded the imposition of damage liability; the

court did not decide whether SCM was entitled to equitable

relief. (PA 109a-10a).

The court of appeals affirmed, holding that “the policies of

the patent laws preclude the imposition of antitrust liability.”

(PA 30a, 32a). The court held that patent law policy requires

that patent purchases be evaluated by focusing “upon the

market power that will be conferred by the patent in relation to

the market position then occupied by the acquiring party.” (PA

28a). Thus, the fact that Xerox’s patent purchases were made

prior to the emergence of a relevant market embodying the

patented inventions precluded antitrust liability, irrespective of

the jury’s finding that, in 1956, it was reasonably foreseeable

that the result of the purchases would be the monopolization

of a relevant market. (PA 28a-35a). The only basis advanced

for the court’s ruling was its policy determination that a

contrary result would “trample upon the incentives provided

by our patent laws” (PA 30a, 32a, 35a). The court also held

that the policies of the patent laws preclude application of the

rule (e.g., United States v. E.1. duPont de Nemours & Co., 353

U.S. 586 (1957)) that the legality under the antitrust laws of an

acquisition may be tested at the time its anticompetitive effects

occur. (PA 32a-36a). Again, the sole justification for the ruling

was that “[t]o hold otherwise would unduly trespass upon the

policies that underlie the patent law system.” (PA 36a). Having

held that Xerox’s patent purchases were not illegal, the court

determined that Xerox’s refusal to license SCM in 1969 could

not be a basis for antitrust liability, even though “in an

economic sense, [the license refusal] might have been unrea-

sonable” (PA 25a, 30a, 32a). Judge Waterman concurred in the

result.

10

REASONS FOR GRANTING THE WRIT

I. In Creating an Exemption From the Antitrust Laws by

Reason of “the policies of the patent laws,” the Court of

Appeals Decided an Important Question of Federal Law

That Should Be Resolved by This Court

This case deals with the principal evil at which the antitrust

laws are aimed—persistent, substantial economic monopoly.’

The court of appeals did not strive to maximize the policies

underlying both the antitrust laws and the patent laws; instead,

the court held that the patent laws oust the antitrust laws

altogether. Under the decision below, the patent laws supersede

the antitrust laws at the very point where antitrust policy is

strongest—in prohibiting the wilful acquisition and main-

tenance of persistent monopoly power. The important ques-

tions raised by that determination should be reviewed by

granting certiorari in this case.

The court of appeals did not dispute that, but for its view of

the policies of the patent laws, there was an antitrust violation

that caused antitrust injury to SCM. The court found in favor

of Xerox, not on the basis that its conduct was, on balance,

procompetitive—the test of legality under the antitrust laws

(see National Society of Pi fessional Engineers v. United

States, 435 U.S. 679, 688-92 (1978))—but on the basis that the

patent laws preclude the imposition of antitrust liability. (PA

30a, 32a, 36a). Xerox’s conduct was, thus, exempted from

antitrust scrutiny.®

8 See, e.g., Standard Oil Co. v. United States, 221 U.S. 1, 52 (1911);

American Tobacco Co. v. United States, 328 U.S. 781, 813 (1946) (quoting

United States v. Aluminum Co. of America, 148 F.2d 416, 427 (2d Cir.

1945)); United States v. Griffith, 334 U.S. 100, 107 (1948); United States v.

United Shoe Machinery Corp., 110 F. Supp. 295, 345 (D. Mass. 1953), aff'd

per curiam, 347 U.S. 521 (1954).

9 The court of appeals, like the district court, did not disturb any of the

jury’s findings on the 1969 exclusion claim, including the finding that the

anticompetitive effects of Xerox's conduct outweighed any claimed procom-

petitive effects. Consequently, in its present posture, this case does not turn

on disputed facts, and this Court need not review any fact findings.

11

There is no express exemption from the antitrust laws for

purchases of patents, as the court below recognized. (PA

22a).'° Nevertheless, the court of appeals held that patent law

policy shields from antitrust review all purchases of patents

made prior to the emergence of a separate, definable relevant

market embodying the patented invention. Under the court’s

decision, every such purchase is per se lawful, not only at the

tune the purchase is made, but forever. Accordingly, if the

market has not yet emerged at the time of the purchase, the

purchaser may forever refuse to license the patents and use

them to exclude competition—even after wilfully attaining

monopoly power.

The court of appeals’ decision casts aside important doc-

trines of antitrust law. Were it not for “the policies of the

patent laws,” the antitrust laws would require that the jury’s

determination that the 1956 Agreement was unlawful when

made be sustained; for it has long been established that “(t]he

anti-trust laws are as much violated by the prevention of

competition as by its destruction.” United States v. Griffith,

334 U.S. 100, 107 (1948); United States v. Aluminum Co. of

America, 148 F.2d 416, 431 (2d Cir. 1945). (See pp. 19-20,

infra). Were it not for “the policies of the patent laws,” the

antitrust laws would require that the jury’s determination that

the 1956 Agreement was unlawful in 1969 also be sustained;

for it has long been established that antitrust scrutiny of an

acquisition is not limited to the time the acquisition is made.

An acquisition lawful at its inception may violate the antitrust

laws thereafter if it develops a demonstrably adverse effect on

competition. E.g., United States v. E.I. duPont de Nemours &

Co., 353 U.S. 586 (1957); United States v. Southern Pacific

Co., 259 U.S. 214 (1922). (See pp. 22-25, infra).

As the district court observed, “[t]his case presents impor-

tant issues concerning the relationship between the patent laws

10 See Kobe, Inc. v. Dempsey Pump Co., 198 F.2d 416 (10th Cir.), cert.

denied, 344 U.S. 837 (1952); United States v. Besser Mfg. Co., 96 F. Supp.

304 (E.D. Mich. 1951), aff'd, 343 U.S. 444 (1952).

12

and the antitrust laws.” (PA 4la).'' And the creation of an

exemption from the antitrust laws is the kind of important

question for which this Court has frequently granted review—

particularly where, as here, an exemption has been implied

without any demonstration of a plain repugnancy between the

two statutory schemes.'? (See pp. 13-18, infra).

Review is especially appropriate and timely in this case, for

the court of appeals’ exemption clears the way for long-term

monopolies in new technologies and products. In high techno-

logy industries, purchases of a number of patents may, as here,

exclude competitors from the relevant market for many years

beyond the 17 granted for the first patented invention. The

purchaser may obtain an overwhelming technological advan-

tage over would-be entrants into the industry; and, if the

antitrust laws cannot apply, that advantage can be extended

into a monopoly of indefinite duration. See Transparent-Wrap

Machine Corp. v. Stokes & Smith Co., 329 U.S. 637, 646-47

(1947).

In this case, for example, Carlson invented xerography in

1937 and his first patent was issued in 1940. Yet, by purchasing

hundreds of patents and patent applications pursuant to the

1956 Agreement, Xerox was able to exclude SCM from plain

paper copying in 1969, twenty-nine years after the first patent

issued. Companies such as SCM and IBM spent fortunes in

unsuccessful efforts to invent around the patents Xerox had

1! The importance of the antitrust-patent relationship itself is reflected by

this Court’s grants of certiorari in cases where the two laws have been

perceived to conflict. See, e.g., Motion Picture Patents Co. v. Universal Film

Mfg. Co., 243 U.S. 502 (1917); B.B. Chemical Co. v. Ellis, 314 U.S. 495

(1942); Transparent-Wrap Machine Corp. v. Stokes & Smith Co., 329 U.S,

637 (1947); Walker Process Equipment, Inc. v. Food Machinery & Chemical

Corp., 382 U.S. 172 (1965); Dawson Chemical Co. v. Rohm & Haas Co., 448

U.S. 176 (1980).

12 E.g., National Gerimedical Hospital & Gerontology Center v. Blue Cross

of Kansas City, No. 80-802 (argued April 29, 1981); California Retail Liquor

Dealers Ass'n v. Midcal Aluminum, Inc., 445 U.S. 97 (1980); Group Life &

Health Ins. Co. v. Royal Drug Co., 440 U.S. 205 (1979); National Broiler

Marketing Ass'n v. United States, 436 U.S. 816 (1978).

13

purchased. No one ever succeeded in circumventing Xerox’s

“solid wall of patent protection.” (E 1553). If it were not for

the antitrust laws, there would be no other companies market-

ing plain paper copiers even today.!3

By forever foreclosing application of the antitrust laws to

patent purchases made prior to the emergence of a relevant

market, the decision below fosters the needless elimination of

competition in the development of new markets. The conse-

quences of the court of appeals’ decision will become increas-

ingly important as scientific breakthroughs occur in such areas

as genetic engineering, laser technology and electronics, to

name but a few examples, where important new markets and

submarkets will be created. Cf. Diamond v. Chakrabarty, 447

U.S. 303 (1980). Whether the policies underlying the patent

laws require an exemption from the antitrust laws for pur-

chases of patent-based monopolies in developing new indus-

tries, solely because a market may not have emerged when the

purchases are made, is an important question that should be

addressed by this Court.

Il. The Exemption Created by the Court of Appeals Is

Unwarranted and Conflicts With Applicable Decisions of

this Court

A. The court of appeals’ decision conflicts with applic-

able decisions of this Court governing implied exemptions

The decision of the court of appeals conflicts with this

Court’s decisions governing implied exemptions from the anti-

trust laws. This Court has never ruled that patents confer

13 The Federal Trade Commission filed a complaint in 1973 charging Xerox

with monopolization. In 1975, Xerox agreed to a consent order requiring it

to license all its patents in return for nominal royalties. (PA 12a). If it had

not been for the FTC decree, Xerox would still have a complete monopoly

today, forty-one years after the first patent issued.

One of the important patents Xerox purchased from Battelle pursuant to

the 1956 Agreement was a 1970 patent that will not expire until 1987; this

patent was infringed by copiers introduced by Dennison and IBM. (A 2098;

E 2301; SA 199b-c). Another “crucial” purchased patent, which several

machines infringed, was a 1961 patent that did not expire until 1978. (A

2094; E 2291, 2980-84; SA 199b-c).

14

immunity from the antitrust laws. To the contrary, as the Court

unanimously held in Standard Sanitary Mfg. Co. v. United

States, 226 U.S. 20, 49 (1912):

“Rights conferred by patents are indeed very definite and

extensive, but they do not give any more than other rights

an universal license against positive prohibitions. The

Sherman law is a limitation of rights, rights which may be

pushed to evil consequences and therefore restrained.” '4

Because our national policy in favor of competition is so

fundamental,'5 this Court’s decisions “have repeatedly es-

tablished that there is a heavy presumption against implicit

exemptions [from the antitrust laws], United States v. Phila-

delphia National Bank, 374 U.S. 321, 350-351 (1963); Califor-

nia v. FPC, 369 U.S. 482, 485 (1962).” Goldfarb v. Virginia

State Bar, 421 U.S. 773, 787 (1975). No exemption will be

recognized unless there is a “plain repugnancy” between the

antitrust laws and the competing statutory system such that no

reconciliation is possible. FMC v. Seatrain Lines, Inc., 411

U.S. 726, 733 (1973); United States v. Philadelphia National

Bank, 374 U.S. at 350-52; United States v. Borden Co., 308

U.S. 188, 198-200 (1939). Thus, an exemption will be “implied

only if necessary to make [the competing statute] work, and

14 Accord, United States v. Masonite Corp., 316 U.S. 265, 280 (1942)

(“{s]ince patents are privileges restrictive of a free economy, the rights which

Congress has attached to them must be strictly construed so as not to

derogate from the general law beyond the necessary requirements of the

patent statute”); see Deepsouth Packing Co. v. Laitram Corp., 406 U.S. 518,

529-31 (1972); United States v. Singer Mfg. Co., 374 U.S. 174, 197 (1963);

United States v. Line Material Co., 333 U.S. 287, 310-11 (1948); B.B.

Chemical Co. v. Ellis, 314 U.S. 495, 498 (1942).

1S The antitrust laws “are the Magna Carta of free enterprise. They are as

important to the preservation of economic freedom and our free-enterprise

system as the Bill of Rights is to the protection of our fundamental personal

freedoms.” California Retail Liquor Dealers Ass’n v. Midcal Aluminum,

Inc., 445 U.S. 97, 110 (1980) (quoting United States v. Topco Associates, 405

U.S. 596, 610 (1972)). In enacting the antitrust laws, Congress “sought to

establish a regime of competition as the fundamental principle governing

commerce in this country.” City of Lafayette v. Louisiana Power & Light

Co., 435 U.S. 389, 398 (1978).

15

even then only to the minimum extent necessary.” Si/ver v. New

York Stock Exchange, 373 U.S, 341, 357 (1963).'¢

This Court's decisions require more than ipse dixit to dem-

onstrate the existence of a plain repugnancy. Yet the court of

appeals relied on no empirical data to support its view that

application of the antitrust laws “would severely trample upon

the incentives provided by our patent laws” (PA 23a, 30a), and

the available empirical data—including the findings in this

case—refute the necessity for an exemption. See F.M.

SCHERER, THE ECONOMIC EFFECTS OF (COMPULSORY PATENT

LICENSING 34, 84-88 (NYU Bus, Admin, Monograph) (1977);

Stedman, The Patent-Antitrust Interface, 58 J. PAT. OFF.

Soc’y 316, 323-24 (1976). Nor did the court of appeals rely on

any of this Court’s opinions. The decision was based only on

the panel’s own unsubstantiated conclusions.

The exemption created by the court below is especially

dangerous because it allows private parties to engage in anti-

competitive conduct unsupervised either by a regulatory agency

or by the constraint of the antitrust laws. E.g., Otter Tail

Power Co. v, United States, 410 U.S, 366, 374 (1973). Where

implied antitrust exemptions are recognized, it is almost invari-

ably in the context of an overriding regulatory scheme with the

supervision of a federal or state agency. In the patent context,

the antitrust laws are the only check on anticompetitive activi-

ties and they must be applied vigilantly to prevent the patent

owner’s conduct from exceeding the limits reasonably neces-

sary to effectuate the purposes of the patent laws.

B. The creation of an implied exemption is unnecessary to

further the policies of the patent laws ‘

There is no “plain repugnancy” between the antitrust laws

and the patent laws to support the exemption created by the

court of appeals. The Constitution gives Congress the power to

16 See, e.g., Group Life & Health Ins. Co, v. Royal Drug Co., 440 U.S,

205, 231-33 (1979); Connell Construction Co, v. Plumbers Local 100, 421

U.S. 616, 625 (1975); Otter Tail Power Co, v, United States, 410 U.S, 366,

372-75 (1973); Carnation Co, v. Pacific Westbound Conference, 383 U.S.

213, 218 (1966).

16

“secur[e] for limited times to. . . inventors the exclusive right

to their. . . inventions” in order to “promote the progress of

science and useful arts” (Art. I, § 8, cl. 8). Thus, the primary

policy underlying the patent laws is that of stimulating inven-

tion, See Dawson Chemical Co, v. Rohm & Haas Co,, 448

U.S. 176, 221 (1980), But the limited grant of exclusivity given

by the patent laws to the inventor to encourage innovation, 35

U.S.C. § 154, need not conflict with the procompetition man-

date of the antitrust laws; for innovation is a goal furthered

not just by the patent laws, but by the antitrust laws as well.

As Learned Hand said in United States v. Aluminum Co, of

America, 148 F.2d 416, 427 (2d Cir, 1945), it is a major premise

of the antitrust laws that “rivalry is a stimulant to industrial

progress; that the spur of constant stress is necessary to

counteract an inevitable disposition to let well enough alone.”

The Department of Justice takes the same position in its recent

ANTITRUST GUIDE CONCERNING RESEARCH JOINT VEN.

TURES 2-3 (1980);

“Competition is both a cause and an effect of new and

improved products and services and more efficient pro-

ductive processes. Competition acts as a spur to en-

courage investment in research, for the firm that fails to

make such investments risks losing business to rivals who

introduce better or cheaper products. Furthermore, the

more competitive the industry, the greater the incentive to

innovate is likely to be, At the same time, investment in

research acts to increase competition, for the successful

innovator gains a competitive advantage over its rivals,

who must then imitate the innovation or develop innova-

tions of their own if they are to keep up in the competitive

race. Antitrust policy strives, therefore, to keep markets

competitive in order to promote innovation, and to en-

courage innovation in order to promote competition.”

The court of appeals’ implied exemption is entirely unneces-

sary to further the purposes of the patent laws because the

policies the patent laws seek to promote are given full expres-

17

sion under the antitrust Rule of Reason, See Silver v. New

York Stock Exchange, 373 U.S. at 360-61; United States v.

Borden Co.,, 308 U.S, at 198. SCM did not contend below that

all purchases of dominant patents were illegal; it simply

urged—as the district court had instructed the jury (A 4513-19,

4527-33; see also A 4422-28, 4461-63, 4549-50)—that such

purchases, including purchases of patents prior to the emer

gence of a relevant market, were subject to the Rule of Reason,

(E.g., SCM’s Reply Brief at 27, quoted by the court of appeals

(PA 28a)).

As this Court held in United States v. United States Gypsum

Co., 333 U.S. 364, 400-01 (1948): “We apply the ‘rule of

reason’ of Standard Oil Co, v. United States, 221 U.S. 1, to

efforts to monopolize through patents as well as in non-patent

fields.” Under the Rule of Reason, when an agreement to

purchase patents eliminates an existing potential for competi-

tion in a reasonably foreseeable economic market, the agree-

ment can be found unreasonable where, as here, it restrains

competition to a degree greater than reasonably necessary to

induce the purchaser to develop and market the product

involved. So applied, the Rule of Reason gives full effect to the

policies of the patent laws, for it allows purchasers of patents

whatever exclusivity is reasonably necessary to induce commer.

cial development. And it also achieves the purposes of the

antitrust laws by preventing those restraints on competition

that are not reasonably necessary to achieve the purposes of

the patent laws. C/. Broadcast Music, Inc. v. Columbia Broad-

casting System, Inc., 441 U.S. 1, 19 (1979),"

The reasonableness of trade restraints has been determined

from the beginning by the standard of reasonable necessity.

17 Contrary to the court of appeals’ assertion (PA 29a), the legality of

patent purchases does not turn, under the Rule of Reason, on the patents’

potential for commercial success; it turns on the degree competition is

restrained in relation to the reasonable need to restrain competition, Nor

does the Rule of Reason condemn purchase agreements that have no

substantial impact on competition, The question in every case is whether

there is a substantial effect on competition, and, if there is, whether the

restraint on competition is reasonably necessary.

United States v. Addyston Pipe & Steel Co., 85 F. 271, 281-82

(6th Cir, 1898), aff'd as modified, 175 U.S, 211 (1899).'* And

the enforcement authorities and the courts have repeatedly

applied the Rule of Reason in determining the legality of

patent-based trade restraints. See Mannington Mills, Inc. v.

Congoleui: industries, Inc., 610 F.2d 1059, 1070-71 (3d Cir.

1979); Moraine Products v. ICI America, Inc,, 538 F.2d 134,

145 (7th Cir.), cert. denied, 429 U.S. 941 (1976); DEPARTMENT

OF JUSTICE, ANTITRUST GUIDE CONCERNING RESEARCH

JOINT VENTURES App. B, at 6-7 (1980).'® Whether the patent

laws are so plainly repugnant to the antitrust laws as to

warrant the exemption created by the court of appeals is an

important question of federal law which this Court should

resolve.

8 CS. 35 U.S.C. § 20%c), 42 U.S.C. § 5908 and 42 U.S.C, § 7608, which

apply a Rule of Reason standard to the Government in the licensing of

federally-owned patents, Under 35 U.S.C, § 209(c), for example, a federal

agency may grant exclusive or partially exclusive licenses on federally-owned

inventions only if: (i) commercial application has not been achieved; (ii)

“exclusive or partially exclusive licensing is a reasonable and necessary

incentive to call forth the investment of risk capital and expenditures to bring

the invention to practical application”; and (iii) “the proposed terms and

scope of exclusivity are not greater than reasonably necessary to provide the

incentive... .”

19 As noted in the Antitrust Guine Conceanina Researcn Jour Ventures, in

1975, the Salk Institute for Biological Studies (a non-profit research founda-

tion) sought a business review letter regarding a proposed licensing program

for its patents and patent applications on the drug somatostatin, Salk lacked

the capability of performing clinical testing for the drug, and therefore

approached several pharmaceutical companies, offering them non-exclusive

licenses for testing and commercial development. The pharmaceutical com-

panies only wanted exclusive licenses and no one accepted the offer, Salk

then asked the Antitrust Division to approve a proposal under which it would

grant non-exclusive licenses, but grant no more than five worldwide licenses.

This limitation on worldwide licenses would expire three years after the first

commercial sale of somatostatin in the United States. Even though the drug

had not been marketed, the Division at first refused to grant a favorable

review because of the anticompetitive potential of the licensee limitation.

However, after learning of Salk's unsuccessful efforts to license non-exclu-

sively, the Division granted a favorable review because the licensee limitation

was reasonably necessary to induce investment by the firms in testing and

developing the drug and because the arrangement limited the power of those

firms to control licensing of the drug to a reasonably brief period.

19

C. There is no basis for a distinction between patent pur-

chases made prior to and those made subsequent to the

emergence of a relevant market embodying the patented

invention; and the distinction disregards the impact on

potential competition

The court of appeals acknowledged that the antitrust laws

“surely” apply to patent purchases made subsequent to the

emergence of a market. (PA 22a-23a). But because the conven-

ience office copying business had not yet become a separate

“market” by 1956, the court of appeals determined that the

1956 Agreement—pursuant to which Xerox purchased hun-

dreds of patents and patent applications, bought up Battelle’s

know-how and eliminated Battelle’s ability to compel subli-

censing—was per se lawful under Sections 1 and 2 of the

Sherman Act and Section 7 of the Clayton Act when the

purchase was made.

There is no justification in antitrust policy for the court of

appeals’ determination. The court’s conclusion that the 1956

Agreement was not illegal disregards the potential competition

that the agreement eliminated.2° No court has ever suggested as

a matter of antitrust policy that the elimination of potential

competition can be ignored because the precise market in

which the effect on competition is measured does not emerge

until a later date.

The importance of ascertaining a relevant market in an

antitrust case is simply to aid in determining the effect on

competition of the agreement at issue. Where the agreement’s

prospective effect on competition is reasonably foreseeable,

and especially where that effect actually occurs, the existence

of a precisely defined market at the time of the agreement is

20 The court below noted that Xerox purchased the patents from an entity

that was not a potential competitor. However, it was established below that,

but for the 1956 Agreement, Battelle would have exercised its power to

compel sublicenses in favor of SCM, among others, by 1969. (PA 123a; A

4575-77). Thus, although Battelle itself was not a potential manufacturing

competitor, it clearly was a source of potential competition. The 1956

Agreement eliminated that potential competition; and, as a result, the 1969

market was monopolized.

20

unnecessary; it is enough to know that the agreement’s effect

on competition will be substantially adverse.

SCM’s injury was suffered, not in 1956, but in 1969, when

Xerox acted to maintain its monopoly power by refusing to

license the patents it had purchased from Battelle. To focus

solely on 1956 is to ignore the impact of the 1956 Agreemerit

on competition. As a matter of antitrust law, the pertinent

inquiry is not what the effect of an agreement is at an isolated

point in time, but what the effect of the agreement is “on

competitive conditions” in the “long-run.” National Society of

Professional Engineers v. United States, 435 U.S. 679, 688-89

(1978). That inquiry cannot ignore the effect of the agreement

on reasonably foreseeable competition, particularly when the

agreement results in the creation and maintenance of persist-

ent, substantial monopoly power.?!

The court of appeals found no basis in a: ‘itrust policy for

conclusively presuming the legality of patent purchases prior to

the emergence of a market; the court’s rule of per se legality

was bottomed only on “the policies of the patent laws.” The

sole rationale advanced by the court of appeals for its distinc-

tion between patent purchases made prior to the emergence of

a market and patent purchases made thereafter was that “to

impose antitrust liability upon Xerox would severely trample

upon the incentives provided by our patent laws” (PA 30a).

But the same reasoning would equally justify an exemption for

all patent purchases, no matter when they are made. Subject-

ing to antitrust scrutiny patent purchases that occur after the

emergence of a relevant market may also diminish economic

incentives.?2

2! By focusing solely on market conditions at the time patents are pur-

chased, the court of appeals would allow a company with a patent on a cure

for cancer, for example, to buy the only significant competing patent as long

as neither product had yet been marketed. The result would be no additional

innovation, and the monopolization of an important new market as soon as

the drugs are sold.

22 The court of appeals rationale proves too much. Virtually every patent

license restriction could be exempted from antitrust scrutiny on the court’s

analysis. Even tying arrangements and closed patent pools could be ap-

21

The court of appeals assumed that, in order to encourage

research investment, it is necessary to conclusively presume the

legality of all purchases of patents prior to the emergence of a

relevant market. The facts of this case demonstrate that the

court’s assumption is incorrect. Xerox, which aiready had a

license to practice the Battelle inventions, and which viewed

plain paper copying’s future as so clearly profitable that it

valued a non-exclusive license at $70 million, would have

produced a commercial copier with or without the monopoly

power acquired as a result of the 1956 Agreement. The 1956

Agreement had nothing to do with investment incentives. As

noted in Xerox’s summation, the “1956 agreement did nothing

to alter the course of Xerox’s continuing R & D efforts.” (A

4313).

The court of appeals found no reason to distinguish between

the economic monopoly obtained through purchases of patents

prior to the emergence of a market and that achieved by an

inventor. (PA 23a & n.9). But one of the basic themes underly-

ing the antitrust laws is that “corporate growth by internal

expansion is socially preferable to growth by acquisition.”

United States v. Philadelphia National Bank, 374 U.S. 321,

370 (1963). And the distinction between “growth... as a

consequence of a superior product,” United States v. Grinnell

Corp., 384 U.S. 563, 570-71 (1966), and growth by acquisition

lies at the very foundation of antitrust policy. See 1 R.

NORDHAUS, PATENT-ANTITRUST LAW § 10 (1980).23 Whether

proved; for those unlawful activities also tend to increase patentee income

and the prohibition of those practices, therefore, arguably—but no more

demonstrably than here—also diminishes the incentives provided by the

patent laws. Cf. B.B. Chemical Co. v. Ellis, 314 U.S. 495, 498 (1942). The

breadth of the court of appeals’ rationale is perhaps best illustrated by the

court’s expression of uncertainty as to whether damage liability can be

imposed for refusing to license illegally pooled patents (PA 25a n.10)—in

sharp contrast with this Court’s holding in Zenith Radio Corp. v. Hazeltine

Research, Inc., 395 U.S. 100 (1969).

23° Xerox did not invent plain paper copying. The xerographic process was

invented by Carlson and brought to commercial feasibility by Battelle. In

determining that Xerox’s monopoly power was acquired unlawfully, the jury

properly rejected Xerox’s contention that its monopoly was achieved by

Xerox’s superior skill. (A 4469-71; SA 831).

22

that distinction can be erased in the patent context is an issue

deserving review by this Court.

Ill. The Decision of the Court of Appeals Conflicts With

Applicable Decisions of This Court Holding That the

Legality of an Acquisition Under the Antitrust Laws May

Be Determined at the Time Its Anticompetitive Effects

Occur

Absent an implied exemption based on the patent laws, even

if the 1956 Agreement had been lawful when it was made, it

clearly became unlawful by 1969, by which time Xerox had

obtained an economic monopoly. Applying the antitrust laws,

the agreement was illegal in 1969 under the established rule

that the legality of an acquisition may be tested, not only at the

time it is made, but also at any later time when the anticom-

petitive consequences of the acquisition have become demon-

strable. Expressing evident dissatisfaction with this rule regard-

less of its context (PA 36a), the court of appeals held that it

could never be applied to patent purchases. The court’s brief

discussion of the issue cited nothing in support of its conclu-

sion. (PA 33a, 36a).

The applicability of the rule that an acquisition may be

found unlawful when its anticompetitive consequences occur is

clearly established under Section 7 of the Clayton Act under

this Court’s decision in United States v. E.I. duPont de

Nemours & Co., 353 U.S. 586, 592, 597, 607 (1957). The

duPont rule was reaffirmed in United States v. Penn-Olin

Chemical Co., 378 U.S. 158, 168 (1964), and United States v.

ITT Continental Baking Co., 420 U.S. 223, 240-43 (1975).24

24 Congress is aware of the duPont rule, and has implicitly endorsed it. Just

last year, Section 7 was expanded to reach acquisitions by and from

individuals and unincorporated firms as well as corporations. Pub. L. No.

96-349, § 6(a), 94 Stat. 1157-58 (1980). The point was raised in opposition to

the bill that, under duPont, “section 7 can be utilized to reach far back into

history. . . .” Hearings on S. 390 before the Subcomm. on Antitrust and

Monopoly of the Senate Comm. on the Judiciary, 96th Cong., Ist Sess. 69-70

(1979). Congress nonetheless passed the bill and extended the reach of

Section 7.

23

The same rule is applicable when acquisitions are challenged

under Sections | and 2 of the Sherman Act. In United States v.

Southern Pacific Co., 259 U.S. 214, 232-33 (1922), for exam-

ple, this Court sustained the Government’s 1914 challenge to

an 1899 stock acquisition over the defense that the acquiring

company had had effective control over the acquired company

since 1870. And in Appalachian Coals, Inc. v. United States,

288 U.S. 344, 378 (1933), this Court ruled that, although the

agreement in issue was not unreasonable at the time it was

made,

“liJf in actual operation it should prove to be an undue

restraint upon interstate commerce, if it should appear

that the plan is used to the impairment of fair competitive

opportunities, the decision upon the present record should

not preclude the Government from seeking the [appropri-

ate] remedy [at such future time].”?5

Even if there were any basis for the court of appeals’

conclusion that application of the Clayton Act’s incipiency

standard under the duPont rule would “unduly trespass upon

the policies” of the patent laws (PA 36a), application of the

doctrine under the Sherman Aci is eminently sound, especially

where, as here, the defendant has obtained an actual monopoly

and is wilfully maintaining it. Only those patent purchases that

unreasonably restrain trade or create a monopoly are con-

demned by Sections 1 and 2 of the Sherman Act. And there is

no empirical support for the proposition that companies will

be deterred from purchasing patents by the prospect that they

might obtain an economic monopoly that could be challenged

in the future under the Sherman Act’s rigorous standard of

proof.6

25. See United States v. Jerrold Electronics Corp., 187 F. Supp. 545, 555-61

(E.D. Pa. 1960), aff’d per curiam, 365 U.S. 567 (1961); United States v.

Citizens & Southern Nat’l Bank, 422 U.S. 86, 143 (1975) (Brennan, J.,

dissenting on other grounds); United States v. E.i. duPont de Nemours &

Co., 353 U.S. at 622 n.14 (Burton, J., dissenting on other grounds).

26 As the Third Circuit has pointed out, “there is a consensus among those

who have considered the question that . . . any incremental increase in

24

The court of appeals acknowledged that, “in an economic

sense, it might have been unreasonable” for Xerox to refuse to

license SCM in 1969, but the court held that the policies of the

patent laws nevertheless rendered the refusal to license lawful.

(PA 32a). Yet Xerox never offered any justification for its 1969

license refusal; and the court did not specify how patent law

policies would be threatened by holding that Xerox violated

the antitrust laws in 1969 when it unreasonably maintained its

monopoly power by refusing to license SCM. Holding that

Xerox acted unlawfully in 1969 by refusing to license other

companies to compete with plain paper copiers—in return for

profitable royalties—would have no adverse impact on any

incentives to invest in innovation.2”? Rather than detrimentally

affecting the patent laws, imposition of liability on Xerox for

its 1969 license refusal would only reaffirm our national

commitment to competition.*

patentee income that might result from permitting licensing schemes that

would otherwise violate the antitrust laws would be unlikely to affect a

patentee’s initial decision to invest in innovative activity.” Mannington Mills,

Inc. v. Congoleum Industries, Inc., 610 F.2d at 1071 (citing authorities).

27. If Sherman Acct liability is imposed in this case, it will only be well after

the time that Xerox’s investment in xerographic research and development

has been recouped many times over. Xerox invested less than $10 million in

xerographic research and development in the 13 years prior to commencing

the marketing of plain paper copiers in 1960; but by 1969, when the jury

found that Xerox had unreasonably excluded SCM, Xerox had already made

$778 million in profits as a result of the patents it had bought from Battelle.

(A 2114-16; E 2665, 3754). Accordingly, Xerox’s 1969 refusal to license

SCM, unlike the license refusal in Dawson Chemical Co. v. Rohm & Haas

Co., 448 U.S. 176, 222-23 (1980), and unlike the refusal to predisclose in

Berkey Photo, Inc. v. Eastman Kodak Co., 603 F.2d 263 (2d Cir. 1979), cert.

denied, 444 U.S. 1093 (1980), cannot be justified by any need to encourage

innovation; and Xerox has not contended otherwise.

28 See Otter Tail Power Co. v. United States, 410 U.S. 366 (1973); Zenith

Radio Corp. v. Hazeltine Research, Inc., 395 U.S. 100, 114-25 (1969);

Hanover Shoe, Inc. v. United Shoe Machinery Corp., 392 U.S. 481 (1968);

Lorain Journal Co. v. United States, 342 U.S. 143 (1951); Eastman Kodak

Co. v. Southern Photo Materials Co., 273 U.S. 359 (1927); United States v.

Terminal Railroad Ass’n, 224 U.S. 383 (1912); Hecht v. Pro-Football, Inc.,

570 F.2d 982, 992-93 & n.44 (D.C. Cir. 1977), cert. denied, 436 U.S. 956

(1978).

25

In refusing to apply duPont to patent purchases, the court of

appeals said that, “[w]here a company has acquired patents

lawfully, it must be entitled to hold them free from the threat

of antitrust liability for the seventeen years that the patent laws

provide.” (PA 36a). The court’s suggestion that the 17-year

period can never be limited by the antitrust laws is demon-

strably wrong. To take an obvious example, the 17-year protec-

tion is lost when patents are illegally pooled. In such circum-

stances even a good faith infringement suit on a valid patent

may not be maintained; it is an unlawful act of monopolization

for which treble damages may be recovered. E.g., Zenith

Radio Corp. v. Hazeltine Research, Inc., 395 U.S. 100, 114-25

(1969); Kobe, Inc. v. Dempsey Pump Co., 198 F.2d 416 (10th

Cir.), cert. denied, 344 U.S. 837 (1952). The 17-year period is

simply the maximum beyond which there is never any protec-

tion.

The policy underlying the duPont doctrine is sound. The

anticompetitive effects of an acquisition may not become

demonstrable until well after the acquisition has been consum-

mated. Yet the impact on competition of an acquisition is not

made any less pernicious because the acquisition is old—a fact

no less true when the assets purchased are hundreds of patents

and patent applications.

The only basis even hinted at below for not applying duPont

to patent purchases is the assumption that the patent laws

themselves will effectively limit to 17 years the duration of the

restraint on competition caused by such purchases. (PA 36a).

But that assumption is disproved by the facts of this very case.

The 1956 Agreement enabled Xerox to purchase an insur-

mountable patent position in plain paper copying, which, as

Xerox commented in 1962, would extend into “the indefinite

future.” (E 172). In 1969, when Xerox refused to license SCM,

it had a complete economic monopoly—twenty-nine years after

the first patent issued. The court of appeals’ decision allows

monopolies of indefinite duration to be established and main-

tained. Whether the policies of the patent laws mandate such a

result is a question this Court should address.

26

CONCLUSION

For the reasons stated, this petition for a writ of certiorari

should be granted.

Respectfully submitted,

GORDON B. SPIVACK

25 Broadway

New York, N.Y. 10004

(212) 344-8480

Of Counsel:

IRA B. GRUDBERG DAVID H. MARKS

DAVID L. BELT JONATHAN M. JACOBSON

Jacobs, Jacobs & Grudberg, PC. Lord, Day & Lord

350 Orange Street 25 Broadway

New Haven, Conn. 06503 New York, N.Y. 10004

(203) 772-3100 (212) 344-8480

JEROME GOTKIN BERNARD J. NUSSBAUM

W. THOMAS FAGAN HAROLD C. HIRSHMAN

Widett, Slater & Goldman, PC. Sonnenschein Carlin

60 State Street Nath & Rosenthal

Boston, Mass. 02109 Suite 8000 Sears Tower

(617) 227-7200 233 South Wacker Drive

Chicago, Ill. 60606

June 10, 1981 (312) 876-8000

Appendix A

Opinion of the Court of Appeals

la

UNITED STATES COURT OF APPEALS

FOR THE SECOND CIRCUIT

, =

No. 14—September Term, 1980

(Argued September 17, 1980 Decided March 12, 1981)

Docket No. 79-7017

a

SCM CorPORATION,

Plaintiff-Appellant,

_—V—

XEROX CORPORATION,

Defendant-Appellee.

+

Before:

WATERMAN, FRIENDLY and MESKILL,

Circuit Judges.

a al

Appeal from an order and judgment of the United

States District Court for the District of Connecticut,

Newman, J., dismissing the claims for monetary damages

asserted by the plaintiff in its private antitrust action

brought under the Clayton and Sherman Acts.

Affirmed and remanded.

—

2a

GorpDon B. Spivack, New York, New York

(David H. Marks, Jonathan M. Jacob-

son, Stephen R. Lynch, Lord, Day &

Lord, New York, New York; Ira B. Grud-

berg, David L. Belt, Jacobs, Jacobs &

Grudberg, P.C., New Haven, Connecti-

cut; Jerome Gotkin, W. Thomas Fagan,

Widett, Slater & Goldman, P.C., Boston,

Massachusetts; Bernard J. Nussbaum,

Harold C. Hirshman, Sonnenschein

Carlin Nath & Rosenthal, Chicago, IlIli-

nois, of counsel), for Plaintiff-Appellant.

STANLEY D. ROBINSON, New York, New York

(Milton Handler, Michael Malina, Allen

Kezsbom, Gerald Sobel, Randolph S.

Sherman, Kaye, Scholer, Fierman, Hays

& Handler, New York, New York, Robert

S. Banks, Xerox Corporation, Stamford,

Connecticut, of counsel), for Defendant-

Appellee.

MESKILL, Circuit Judge:

The plaintiff, SCM Corporation (SCM), appeals from

an order entered in the United States District Court for

the District of Connecticut, Jon O. Newman, Judge,

dismissing its claim for monetary damages asserted in this

private antitrust action for injuries sustained as a result of

alleged exclusionary acts committed by the defendant,

Xerox Corporation (Xerox), in violation of §§ 1 and 2 of

the Sherman Act, 15 U.S.C. §§ 1, 2 (1976), and § 7 of the

Clayton Act, 15 U.S.C. § 18 (1976). The trebled amount

3a

of damages calculated by the jury on this claim totalled

$111.3 million. The principal anticompetitive acts alleged

by SCM concerned patent acquisitions made by Xerox.

SCM averred that Xerox’s acquisition of certain patents

and subsequent refusal to license those patents excluded

SCM from competing effectively in a relevant product

market and submarket dominated by Xerox products

that embraced the patented art. Judge Newman ruled

below that a need to accommodate the antitrust and

patent laws precluded damage liability predicated upon

Xerox’s refusal to license its patents; however, he left

open the possibility of granting the plaintiff equitable

relief. Judge Newman certified his order for inierlocutory

review pursuant to 28 U.S.C. § 1292(b) (1976) and, as

developed below, we exercised our discretion under that

section to accept this appeal. Without commenting upon

Judge Newman’s remedial theory, we affirm the denial of

monetary damages in connection with SCM’s exclu-

sionary claim based upon our determination that none of

Xerox’s paterit-related conduct, the only conduct alleged

by SCM to have caused it any harm, contributed to any

antitrust violation.

SCM also appeals from a judgment entered pursuant to

Rule 54(b), 28 U.S.C., Fed. R. Civ. P. 54(b) (1976),

dismissing its claim for monetary damages based upon

injuries sustained as a result of certain marketing pro-

grams it alleged violated § 2 of the Sherman Act and § 3

of the Clayton Act, 15 U.S.C. § 14 (1976). Judge New-

man held that this claim could not support an award of

damages because “the jury [had not been] given a rational

basis for approximating” the damages incurred by SCM.

463 F.Supp. at 1019. We affirm Judge Newman’s deci-

sion.

4a

BACKGROUND

Chester Carlson—The Inventor

In the 1930s, a patent attorney turned inventor, named

Chestor Carlson, invented a process, subsequently called

xerography, that within two decades would revolutionize

the document reproduction industry. The xerographic

process is described in Judge Newman’s opinion below,

reported at 463 F.Supp. 983.

Two adaptations of the xerographic process are particu-

larly relevant to this case. The first is electrofax copying, a

process which involves the reproduction of images on paper

coated with zinc-oxide. The second, xerography in the re-

usable mode, is a more complex process which permits im-

ages to be reproduced on plain paper.

The significance in distinguishing between coated-paper

copying and plain-paper copying is that Xerox, which

later came to control Carlson’s patents and all of the

xerographic improvement patents, agreed to grant li-

censes for coated-paper copying but refused to grant

licenses for plain-paper copying. The result was that from

1960 until 1970, when IBM introduced its first plain-

paper copier, Xerox enjoyed an absolute monopoly in the

plain-paper copying segment of the industry.

Both the plain- and coated-paper copiers were intro-

duced into a market that formerly had been limited to

machines that employed “duplicating” processes as op-

posed to the “copying” processes just described. The

principal duplicating processes then in use were offset,

spirit, and mimeograph, all of which were developed

around the turn of the century. The duplicating processes

all had one common characteristic—they required the

preparation of a master or stencil. Ultimately the copying

machines formed a discrete market in which the duplicat-

Sa

ing machines could not effectively compete; however,

precisely when that even occurred was not determined by

the jury below.

The Carlson-Battelle Relationship

Chester Carlson, from 1940 to 1944, made eighteen

attempts to find a commercial backer for his invention.

Carlson was turned down by IBM on three separate

occasions, two of which involved an offer by Carlson to

sell exclusive rights to all of his patents. Finally, in 1944,

Carlson entered into an agreement with Battelle Memorial

Institute (Battelle), a non-profit research organization

self-described as “in the business of developing and im-

proving technical inventions and in selling the rights

thereon when patented.” Pursuant to this agreement,

Battelle received an exclusive license under Carlson’s

patents; a wholly owned subsidiary, Battelle Development

Corp. was designated as Carlson’s exclusive licensing

agent; and Battelle agreed to pay Carlson forty percent of

any royalties it might receive. Subsequently, Carlson for-

mally assigned his patents to Battelle. Thereafter, Battelle

secured patents covering many improvements it invented

in the xerographic process that would prove to be of vital

importance to the production of an automatic plain-paper

copier.

The Xerox-Battelle Agreements

Between 1944 and 1947 Battelle experienced difficulty,

as had Carlson, in its efforts to secure financial backing.

Carlson and Battelle approached thirty-six companies,

including IBM, but none was sufficiently interested. In

1946 the Haloid Company of Rochester, New York (later

renamed and hereinafter referred to as Xerox) ap-

6a

proached Battelle and offered its assistance in the com-

mercialization of xerography. During the next ten years,

the parties entered into a series of four basic agreements

pursuant to which Xerox acquired complete title to the

Carlson-Battelle patents and exclusive domain over the

plain-paper copying industry. We describe these agree-

ments in some detail.

The first agreement between Xerox and Battelle, exe-

cuted in 1947, denied Xerox the exclusive license it sought

and instead gave it a non-exclusive license covering lim-

ited applications of xerography. Xerox agreed to pay

Battelle an eight percent royalty and to sponsor $25,000

of xerographic research at Battelle a year. The license was

limited to patented inventions that would produce up to

twenty copies of a document. Xerox also agreed to grant

back to Battelle royalty-free rights on any xerographic

patents it might obtain in connection with its own or

sponsored research. Finally, Battelle agreed, as was its

usual practice, not to work for another company in the

xerographic field occupied by Xerox for the term of the

agreement.

The second agreement, executed in 1948, granted

Xerox an exclusive license to the Carlson-Battelle patents,

on the condition that Xerox “use diligent efforts to secure

sublicensees to engage in research, development and com-

mercialization of the inventions and patents” involved.

Additionally, the 20-copy limitation was removed from

the license agreement, affording Xerox more latitude in

its efforts to exploit the commercial potential of xerog-

raphy.

The third agreement, executed in 1951, continued

Xerox’s obligation to use diligent efforts to seek sublicen-

sees, but extended the scope of the license, which under

the 1947 and 1948 agreements had been limited to use in

7a

the United States, to include use worldwide. Additionally,

all remaining limitations on the fields in which Xerox

could practice xerography under the 1948 agreement were

removed.

Before discussing the fourth agreement executed by the

parties in 1956, which is central to SCM’s claims in this

case, it is necessary to describe the circumstances of the

parties and the market at that time. By the early 1950s

Xerox had experienced success in two commercial appli-

cations of xerography. One machine, a flat-plate copier,

which required twenty manual steps and three or four

minutes to produce a single copy, found some market

acceptance for preparing paper masters for offset dupli-

cators. Another machine, the “Copyflo,” a huge machine

weighing approximately one ton, achieved substantial

success in printing microfilm. By 1956, Xerox was deriv-

ing forty percent of its profit from its xerographic prod-

ucts. SCM does not contend that either of these products

found commercial acceptance as convenience office cop-

iers, the product market that SCM claims Xerox domi-

nated for over a decade. Nevertheless, there is evidence in

the record tending to prove that Xerox possessed the

technology in 1955 to manufacture an automatic plain-

paper copier, and that Xerox speculated that the value of

even a non-exclusive license of its xerographic patents was

worth $70 million. Despite its continuing obligation under

the 1948 and 1951 agreements to secure sublicensees,

Xerox turned down license requests from such potential

competitors as IBM, which by then apparently had

formed a different opinion concerning the commercial

feasibility of xerography. Although the record is not clear,

it appears that coated-paper copiers, other than the elec-

trofax (xerographic), had made inroads into the docu-

ment reproduction machine industry by the early 1950s.

8a

These coated-paper copiers included a *‘wet’’ photographic

type process called ‘‘diffusion transfer,’’ marketed by

Apeco, another ‘‘wet’’ process called ‘‘dye transfer,’’ ad-

vanced by Kodak, and a ‘‘dry’’ thermographic process

that used heat-sensitiv: coated paper manufactured by

3M. In 1954 RCA introduced its electrofax machine and

attempted to obtain xerographic licenses from Xerox.

Also in this document reproduction industry in 1956 were

the offset, mimeograph, and spirit machines that by then

had been in use for half a century. (SCM Br. 18-19).' It

was in this context that Xerox entered into its final

agreement with Battelle.

The fourth agreement, executed in 1956, transferred

title to the four basic Carlson-Battelle patents to Xerox

and abrogated Xerox’s sublicensing obligation. In return,

Battelle received 55,000 shares of Xerox stock and a

percentage of Xerox’s profits between 1959 and 1965.

Xerox also received an exclusive license to the remaining

Carlson-Battelle patents, title formally to be assigned on

! SCM did not attempt to define the composition of the relevant

product market in 1956, because SCM did not allege that Xerox’s

conduct at this time was directed at monopolizing the relevant product

market then in existence. The relevant product market, which SCM

claimed Xerox monopolized by 1964, allegedly consisted only of plain-

and coated-paper copiers, and was described as the convenience office

copier market. SCM also argued that plain-paper copiers by 1964

formed a relevant submarket over which Xerox acquired monopoly

control. Xerox on the other hand argued that the relevant product

market included offset, spirit, and mimeograph equipment. In any

event, the jury found the markets suggested by SCM existed in 1969

but not in 1964. In view of SCM’s failure to challenge the jury’s

determination on appeal, we see no reason to disturb the jury’s finding

that the relevant product market and submarket SCM defined did not

exist in 1964,

Thus, we have no clear picture of the relevant product market that

existed in 1956 when Xerox entered into its final agreement with

Battelle that SCM claims violated the antitrust laws.

2 Chester Carlson received 40% of the consideration given Battelle.

9a

January 1, 1959. Additionally, Xerox received the right to

receive all future xerographic patents and know-how

developed by Battelle, provided that Xerox continued to

sponsor research in the amount of $25,000 annually.

Finally, the 1956 agreement eliminated Xerox’s obligation

to assign its own internally developed patents to Battelle.’

On January 2, 1959, the assignment from Battelle to

Xerox of the xerographic improvement patents occurred

pursua't to the terms of the agreement entered into

between the parties in 1956.

Xerox’s International Family of Companies

In 1956 Xerox entered into a joint venture with the

Rank Organisation, a British company, to assist in the

commercial exploitation of xerography everywhere except

the United States and Canada. The agreement created

Rank Xerox, a joint venture. The agreement included a

clause obligating the joint venture to grant Xerox exclu-

sive rights in the United States and Canada to improve-

ment patents it might obtain.‘ The jury found that Rank

was not a potential competitor of Xerox. In any event

there was no agreement that Rank Xerox would not

compete against Xerox in the United States.

In 1960, Rank Xerox formed a separate joint venture

with Fuji Photo Film, a Japanese enterprise. The jury

found that Fuji Photo Film was a potential competitor of

3 In September 1956, Xerox also entered into an agreement with another

research organization named Horizons, Inc. Under the agreement, Hori-

zons granted Xerox non-exclusive licenses under xerographic patents it

had obtained and, like Battelle, agreed to perform xerographic research

exclusively for Xerox. The agreement was renewed in 1960.

4 Xerox received only one grant-back patent which it used in a

commercial product.

10a

Xerox and Rank Xerox. The agreement created Fuji

Xerox. This agreement also contained a grant-back clause

that entitled Xerox to exclusive rights in all countries

except Japan and eight Asian nations to all inventions

Fuji Xerox might make in the xerographic field. There

was no agreement preventing Fuji Xerox from competing

with Xerox in the United States; however, Fuji Xerox was

not licensed under Xerox’s patents in the United States

and thus could not compete in this country in the alleged

plain-paper copier submarket without infringing Xerox’s

patents here. —

In 1969, Xerox purchased an additional one percent of

Rank Xerox’s stock, increasing its stock ownership in the

joint venture to fifty-one percent. Additionally, the grant-

back clause of the joint venture agreement was elimi-

nated.

Xerox Introduces the 914

In March 1960, Xerox made initial deliveries of the 914,

its first automatic plain-paper copier. The 914 was a re-

sounding success. Between 1960 and 1970, Xerox’s reve-

nues rose from $47 million to $1.7 billion; during the same

period its gross profits increased from $6 million to $400

million. By 1975 Xerox’s revenues reached $4 billion and its

gross profits rose to over $800 million.

Xerox enjoyed a complete monopoly in the production

of plain-paper copiers between 1960 and 1970. In 1960

SCM introduced a coated-paper copier that employed a

diffusion transfer process. In 1962 SCM produced an

electrofax coated-paper copier, which infringed some of

Xerox’s patents. Following a brief infringement suit,

Xerox in 1964 granted SCM limited licenses under its

patents to manufacture xerographic coated-paper copiers.

Xerox refused, however, to extend licenses to SCM that

lla

would enable it to manufacture its owi plain-paper cop-

ier. Similar requests were made by SCM in the ensuing

years but repeatedly denied by Xerox. Finally, in 1970,

without obtaining licenses from Xerox, IBM introduced a

plain-paper copier into the market; other companies fol-

lowed IBM’s lead in the early seventies.

Additional Alleged Anticompetitive Conduct of Xerox

a. Employee Covenants Not to Compete

Up until 1970, Xerox imposed upon its employees an

employment condition that in the event they terminated

their employment with Xerox, they could not work for a

competitor for a period of two years. At Xerox’s request,

Battelle imposed a similar restriction on six of its employ-

ees. SCM presented no evidence that it ever attempted to

hire a Xerox or Battelle employee covered by such a

restrictive covenant.

b. MUP and XCP Pricing Plans

In the 1960s Xerox’s only real competition was in the

“low volume” copier market, a market in which coated-

paper copiers could compete because of their relative cost

efficiency at the low-volume usage level. Around 1967

several manufacturers of coated-paper copiers instituted

“volume” or “fleet” pricing plans under which subscrib-

ing customers received discounts based upon the aggre-

gate volume of copies made on all machines used by the

customer.

In 1968 Xerox responded with its own volume pricing

plan entitled the “Machine Utilization Plan” (MUP).

MUP afforded to Xerox customers a discount based upon

the customer’s total volume from both low-volume (an

area in which coated-paper copiers could compete) and

12a

high-volume machines (an area in which coated-paper

copiers could not effectively compete). The MUP plan

was replaced by a similar program, the XCP plan, in

1975. SCM argued that MUP constituted an illegal tying

arrangement that coerced Xerox customers to use Xerox

low-volume machines instead of competitors’ low-volume

copiers to meet minimum volume levels to be eligible for

MUP discounts.

The Federal Trade Commission (FTC) Proceeding

In January 1973 the FTC filed a complaint against Xerox

charging that the company’s conduct had violated § 2 of

the Sherman Act. The FTC sought a decree enjoining

Xerox to license its patents and to sever its relationship with

its affiliated companies. The action was terminated upon

the entry of a consent decree on July 29, 1975 under which

Xerox agreed to license all of its patents in exchange for

nominal royalties and grant-backs of non-exclusive licenses

under all xerographic patents owned by licensees. Thus, as

of July 29, 1975, Xerox’s patents no longer excluded a

potential competitor from the market.

SCM’s Claims and the Decision Below

SCM filed its complaint in this action on July 31, 1973.

Discovery was completed in 1977 and the trial terminated

in 1978 following 215 days in which evidence was pre-

sented and 38 days of jury deliberation. SCM asserted

five claims for monetary damages at trial. See 463

F.Supp. at 986-91. Only two of those claims have been

pursued on this appeal.

13a

a. The 1969 Exclusion Claim

The gist of SCM’s 1969 exclusion claim’ is that by 1969

Xerox had willfully acquired monopoly power in a rele-

vant product market consisting of convenience office

copiers using plain and coated paper and in a relevant

submarket consisting only of plain-paper copiers, and

that Xerox’s conduct excluded SCM from the relevant

market and submarket.

The jury rejected SCM’s argument that the relevant

product market and submarket defined by SCM existed in

1964, but accepted the contention that the market and

submarket so defined existed in 1969. The jury made a

specific finding that the only patent-related conduct of

Xerox causally related to SCM’s claimed injuries under

its 1969 exclusion claim was the 1956 Xerox-Battelle

agreement. The 1956 agreement, therefore, is the only

basis upon which SCM can recover any monetary dam-

$ SCM originally sought to recover damages for financial injuries it

sustained as far back as 1964, the year SCM first requested a license

from Xerox to manufacture its own plain-paper copier.

Since the complaint was filed on July 31, 1973, the period of injury

for which recovery could be sought ordinarily would be governed by

the four-year statute of limitations provided under the antitrust laws,

15 U.S.C. § 15b (1976), and extend back only to July 31, 1969.

Because the FTC instituted a proceeding against Xerox on January 16,

1973, § 16(i) of Title 15 of the United States Code, which tolls the normal

statute of limitations upon the commencement of an FTC proceeding,

extended the period back to January 16, 1969. Finally, Xerox did not

object to including the first two weeks of January, so that January 1, 1969

became the outside date.

SCM asserted, nevertheless, that its injuries sustained in 1964 were

not ascertainable until the FTC proceeding was commenced in 1969

and that, therefore, it was entitled to recovery for losses sustained in

1964. Because of the statute of limitations question, SCM’s claim for

damages prior to 1969 was characterized as a distinct claim—the “1964

Exclusion Claim”—to avoid confusion. SCM has not pursued its 1964

exclusion ciaim on this appeal because the jury found that SCM lacked

the intent, preparedness, and capacity to enter into plain-paper copy-

ing in 1964. Thus, we need not address the statute of limitations issue.

l4a

ages under its 1969 exclusion claims. As Judge Newman

noted below:

SCM cannot predicate damage liability on any non-

patent-related conduct because it neither claimed nor

offered evidence that any such conduct, the post-em-

ployment covenants, for example, caused it any dam-

age. SCM’s entire exclusion damage proof consisted

of the losses suffered by lack of licenses.

463 F.Supp. at 1010.

The jury found that the 1956 agreement constituted an

unreasonable restraint of trade in 1964 and 1969 in

violation of § 1 of the Sherman Act,° and had the

probable effect of substantially lessening competition or

tending to create a monopoly in 1969 in both the conven-

ience office copier market and the plain-paper copier

submarket in violation of § 7 of the Clayton Act.

Upon all of the evidence of Xerox’s alleged anti-com-

petitive conduct, the jury concluded that as of 1969 Xerox

willfully acquired or maintained monopoly power in the

relevant product market and submarket in violation of

§ 2 of the Sherman Act.’ The jury calculated SCM’s

6 The jury rejected SCM’s claim that Xerox had entered into a

concerted refusal to deal with Rank Xerox and Fuji Xerox aimed at

excluding competitors from manufacturing plain-paper copiers world-

wide as of 1964 or 1969.

7 While only Xerox’s patent-related conduct was alleged by SCM to

have caused it any injury, the jury’s finding that Xerox monopolized

the relevant market and submarket in 1969 in violation of § 2 of the

Sherman Act must be presumed to have been based upon the evidence

offered by SCM against Xerox concerning both Xerox’s patent-related

and non-patent-related conduct. The latter category could include the

Horizons Corporation patent acquisition, the grant-backs of licenses

from Xerox’s licensees, the employee covenants not to compete, and

the joint venture agreements entered into between Xerox and the Rank

Organization and Fuji Photo. As Judge Newman observed below,

however, it is likely that the jury primarily relied upon the 1956

Xerox-Battelle agreement as the basis for its § 2 violation finding. See

463 F.Supp. at 1008.

15a

damages under the 1969 exclusion claim at $11.5 million

in lost profits and $25.6 million in lost going concern

value. Trebled, the damages amount to $111.3 million.

The jury found, however, that SCM reasonably could

have avoided all of the 1969 exclusion claim damages by

instituting this action against Xerox earlier.‘

Judge Newman seriously questioned whether any of

Xerox’s conduct had violated any of the antitrust laws.

Judge Newman, however, chose not to disturb the jury

verdicts. Instead, the district court ruled, as a matter of

law, that Xerox’s unilateral refusal to license its patents

was not a basis for a monetary damage award. 463

F.Supp. at 1014-15. Judge Newman opined that this result

was necessary in order to accommodate the antitrust and

patent laws. Jd. He certified his order denying monetary

damages under the 1969 exclusion claim for appeal pur-

suant to 28 U.S.C. § 1292(b) (1976). 463 F.Supp. at 1021.

After remanding the case for further clarification, see 599

F.2d 32, and the district court’s restatement of the ques-

tion certified for interlocutory review, see 474 F.Supp.

589, we exercised our discretionary power by an order

dated May 25, 1979, to accept this interlocutory appeal.

b. The MUP Claim

The jury concluded that Xerox’s MUP constituted an

illegal tying arrangement that violated § 3 of the Clayton

Act, 15 U.S.C. § 14 (1976), as well as an effort by Xerox

to maintain its monopoly power in the relevant market

and submarket in violation of § 2 of the Sherman Act, 15

U.S.C. § 2 (1976). The jury awarded $230,874 to SCM

8 Although we seriously question the appropriateness of applying the

avoidable consequences doctrine to a case such as the one before us,

we need not resolve that issue in light of our holding that the conduct

complained of by SCM did not violate the antitrust laws.

16a

for injuries it sustained as a result of MUP. Judge New-

man set aside the jury’s verdict under the MUP claim on

the ground that the “jury was not given a sufficient basis

from which it could reasonably conclude that the lost

profits claimed by SCM were caused by MUP.” 463

F.Supp. at 1018. The route to appellate review of the

disposition of the MUP claim was found through the

entry of a final judgment on that claim pursuant to Rule

54(b) of the Federal Rules of Civil Procedure.

DISCUSSION

The 1969 Exclusion Claim

SCM argues on this appeal that the economic monop-

oly Xerox achieved through the patents it obtained from

Battelle in 1956 was unlawful. The issue presented on this

appeal in connection with SCM’s 1969 exclusion claim,

however, is not whether any of Xerox’s conduct between

1947 (when it first contacted Battelle) until 1975 (when

Xerox agreed voluntarily to license all of its patents)

violated any of the antitrust laws, but rather, whether any

of Xerox’s conduct during that period caused Xerox to

incur damage liability under the antitrust laws to SCM.

SCM’s damage claim must be predicated upon an “injury

of the type the antitrust laws were intended to prevent

and that flows from that which makes the defendants’

acts unlawful.” Brunswick Corp. v. Pueblo Bowl-O-Mat,

Inc., 429 U.S. 477, 489 (1977); accord, Zenith Radio

Corp. v. Hazeltine Research, Inc., 395 U.S. 100, 114 n.9

(1969); see Areeda, Antitrust Violations Without Damage

Recoveries, 89 Harv. L. Rev. 1127, 1130-37 (1976). SCM

did not contend below that it sustained any injuries other

than by reason of Xerox’s allegedly unlawful patent-re-

lated conduct, and the jury identified the 1956 agreement

17a

as the sole patent-related conduct that caused SCM any

harm. Therefore, only if Xerox’s procurement of the

patents under the 1956 agreement contributed to an

antitrust violation can SCM recover damages under its

1969 exclusion claim.

SCM has argued that Xerox’s acquisition of its patents

and subsequent exercise of the exclusionary power in

them violated the antitrust laws and iniured SCM. Xerox

contends that its acquisition of the patents was lawful and

its decision not to license its patents for plain-paper

copying constituted a lawful exercise of patent power.

Xerox does not dispute that it achieved monopoly power

in the relevant market and submarket by 1969, but

contends that an examination of the circumstances under

which this feat was accomplished reveals the lawfulness

of the monopoly it attained. Our analysis commences

with a review of the relationship between the patent and

antitrust laws.

The patent laws were enacted pursuant to Congress’

authority to “promote the Progress of Science and useful

Arts, by securing for limited Times to . . . Inventors the

exclusive Right to their. . . Discoveries.” U.S. Const.,

Art. I, § 8, cl. 8. That the first patent laws were enacted

at the second session of our first Congress manifests the

importance our founding fathers attached to encouraging

inventive genius, a resource that preved to be bountiful

throughout this nation’s history. The patent laws reward

the inventor with the power to exclude others from

exploiting his invention for a period of seventeen years.

35 U.S.C. § 154 (1976). In return, the public benefits

from the disclosure of inventions, the entrance into the

18a

market of valuable products whose invention might have

been delayed but for the incentives provided by the patent

laws, and the increased competition the patented product

creates in the marketplace. The antitrust laws, on the

other hand, were enacted to protect competition in the

market. The antitrust laws are based upon the fundamen-

tal premise that the public benefits most from a competi-

tive marketplace. Standard Oil Co. v. United States, 221

U.S. 1, 58 (1911); United States v. Aluminum Co. of

America, 148 F.2d 416, 428-29 (2d Cir. 1945).

The conflict between the antitrust and patent laws

arises in the methods they embrace that were designed to

achieve reciprocal goals. While the antitrust laws pro-

scribe unreasonable restraints of competition, the patent

laws reward the inventor with a temporary monopoly that

insulates him from competitive exploitation of his pat-

ented art. When the patented product, as is often the

case, represents merely one of many products that effec-

tively compete in a given product market, few antitrust

problems arise. When, however, the patented product is

so successful that it evolves into its own economic

market, as was the case here, or succeeds in engulfing a

large section of a preexisting product market, the patent

and antitrust laws necessarily clash. In such cases the

primary purpose of the antitrust laws—to preserve com-

petition—can be frustrated, albeit temporarily, by a

holder’s exercise of the patent’s inherent exclusionary

power during its term.

II.

The law is unsettled concerning the effect under the

antitrust laws, if any, that the evolution of a patent

monopoly into an economic monopoly might have upon a

19a

patent holder’s right to exercise the exclusionary power

ordinarily inherent in a patent. Indeed, implicit in Judge

Newman’s decision below is a deep concern over the

uncertain antitrust law implications just such an event

might have had in this case. His thoughtful analysis of the

relationship between the patent and antitrust laws led him

to conclude that “the need to accommodate the patent

laws with the antitrust laws precludes the imposition of

damage liability . . . for a unilateral refusal to license

valid patents.” 463 F.Supp. at 1012-13. Judge Newman

opined that whether or not Xerox’s refusal to license the

patents it acquired under the 1956 agreement transgressed

any provisions of the antitrust laws, monetary damage

liability could not be imposed upon Xerox without se-

riously undermining the patent system. The district

court’s thesis rests on the assumption that despite the

lawfulness of a patent’s acquisition, “[i]n some circum-

stances, [a] refusal to license may be considered a § 2

violation.” 463 F.Supp. at 1012.

SCM has contended that a unilateral refusal to license a

patent should be treated like any other refusal to deal by

a monopolist, see generally Otter Tail Power Co. v.

United States, 410 U.S. 366 (1973); Lorain Journal Co. v.

United States, 342 U.S. 143 (1951); Eastman Kodak Co.

v. Southern Photo Materials Co., 273 U.S. 359 (1927),

where the patent has afforded its holder monopoly power

over an economic market. While, as SCM suggests, a

concerted refusal to license patents is no less unlawful

than other concerted refusals to deal, in such cases the

patent holder abuses his patent by attempting to enlarge

his monopoly beyond the scope of the patent granted

him. See, e.g., Zenith Radio Corp. v. Hazeltine Research,

Inc., supra, 305 U.S. at 118-19; United States v. Singer

Manufacturing Co., 374 U.S. 174, 192-97 (1963); United

20a

States v. Line Material Co., 333 U.S. 287, 314-15 (1948);

Hartford-Empire Co. v. United States, 323 U.S. 386,

406-07 (1945); United States v. Masonite Corp., 316 U.S.

265, 277 (1942). Where a patent holder, however, merely

exercises his “right to exclude others from making, using,

or selling the invention,” 35 U.S.C. § 154 (1976), by

refusing unilaterally to license his patent for its seventeen-

year term, see, e.g., Bement v. National Harrow Co., 186

U.S. 70, 88-90 (1902), such conduct is expressly permitted

by the patent laws. “The heart of [the patentee’s] legal

monopoly is the right to invoke the State’s power to

prevent others from utilizing his discovery without his

consent.” Zenith Radio Corp. v. Hazeltine Research,

Inc., supra, 395 U.S. at 135 (citing Crown Die & Tool Co.

v. Nye Tool & Machine Works, 261 U.S. 24 (1923);

Continental Paper Bag Co. v. Eastern Paper Bag Co.,

210 U.S. 405 (i908)). Simply stated, a patent holder is

permitted to maintain his patent monopoly through con-

duct permissible under the patent laws.

No court has ever held that the antitrust laws require a

patent holder to forfeit the exclusionary power inherent

in his patent the instant his patent monopoly affords him

monopoly power over a relevant product market. In

Alcoa this Court never questioned the legality of the

economic monopoly Alcoa maintained by virtue of the

two successive patents it had acquired. United States v.

Aluminum Co. of America, supra, 148 F.2d at 422, 430.

Indeed, Judge Learned Hand termed Alcoa’s economic

monopoly during the terms of those patents “lawful.” 148

F.2d at 430. We do not interpret Judge Wyzanski’s deci-

sion in United States v. United Shoe Machinery Corp.,

110 F.Supp. 295 (D. Mass. 1953), aff’d per curiam, 347

U.S. 521 (1954), as supporting SCM’s argument to the

contrary. In United Shoe, the primary vehicle found to

2la

have been employed by United Shoe in achieving and

maintaining its monopoly was its lease-only system of

distributing its machines. 110 F.Supp. at 344. The patent

acquisitions scrutinized by Judge Wyzanski occurred after

United Shoe possessed substantial market power and were

not “one of the principal factors . . . enabling [United

Shoe] to achieve and hold its share of the market.” 110

F.Supp. at 312. Thus, contrary to appellant’s contention,

the United Shoe case stands in stark contrast to the one at

bar where the patents were acquired prior to the appear-

ance of the relevant product market and where the pat-

ents themselves afforded Xerox the power to achieve

eventual market dominance.

In Alcoa Judge Learned Hand stated that the “success-

ful competitor, having been urged to compete, must not

be turned upon when he wins.” 148 F.2d at 430. And

while that statement was made in regard to a hypothetical

situation where only one of a group of competitors

ultimately survives, it at least indicates a concern Judge

Hand had for preserving those economic incentives that

provide the primary impetus for competition. Subse-

quently, the Supreme Court in United States v. Grinnell

Corp., 384 U.S. 563 (1966), amplified this consideration

when it set forth the elements of a § 2 violation as

follows:

The offense of monopoly under § 2 of the Sher-

man Act has two elements: (1) the possession of

monopoly power in the relevant market and (2) the

willful acquisition or maintenance of that power as

distinguished from growth or development as a con-

sequence of a superior product, business acumen, or

historic accident.

Id. at 570-71 (emphasis added).

22a

Thus, in Berkey Photo, Inc. v. Eastman Kodak Co.,

603 F.2d 263, 275 (2d Cir. 1979), cert. denied, 444 U.S.

1093 (1980), this Court stated that “[w]Je tolerate the

existence of monopoly power. . . only insofar as neces-

sary to preserve competitive incentives and to be fair to

the firm that has attained its position innocently.” In

United States v. Griffith, 334 U.S. 100 (1948), the Su-

preme Court declared, however, that “the use of monop-

oly power, however lawfully acquired, to foreclose com-

petition, to gain a competitive advantage, or to destroy a

competitor, is unlawful.’’ /d. at 107. Echoing the same

consideration in Berkey, Judge Kaufman stated that while

“(t]he mere possession of monopoly power does not ipso

facto condemn a market participant. . . , the firm must

refrain at all times from conduct directed at smothering

competition.” Berkey Photo, Inc. v. Eastman Kodak Co.,

supra, 603 F.2d at 275.

The tension between the objectives of preserving

economic incentives to enhance competition while at the

same time trying to contain the power a successful com-

petitor acquires is heightened tremendously when the

patent laws come into play. As the facts of this case

demonstrate, the acquisition of a patent can create the

potential for tremendous market power.

Ill.

Patent acquisitions are not immune from the antitrust

laws. Surely, a § 2 violation will have occurred where, for

example, the dominant competitor in a market acquires a

patent covering a substantial share of the same market

that he knows when added to his existing share will afford

him monopoly power. See generally Kobe, Inc. v. Demp-

sey Pump Co., 198 F.2d 416 (10th Cir.), cert. denied, 344

23a

U.S. 837 (1952); United States v. Besser Manufacturing

Co., 96 F.Supp. 304, 310-11 (E.D. Mich. 1951), aff’d, 343

U.S. 444 (1952). That the asset acquired in a patent is

irrelevant; in such a case the patented invention already

has been commercialized successfully, and the magnitude

of the transgression of the antitrust laws’ proscription

against willful aggregations of market power outweighs

substantially the negative effect that the elimination of

that class of purchasers for commercialized patents places

upon the patent system.

The patent system would be seriously undermined,

however, were the threat of potential antitrust liability to

attach upon the acquisition of a patent at a time prior to

the existence of the relevant market and, even more

disconcerting, at a time prior to the commercialization of

the patented art. As SCM itself admits, the procurement

of a patent by the inventor will not violate § 2 even where

it is likely that the patent monopoly will evolve into an

economic monopoly; yet SCM would deny the same

reward to anyone but the patentee.’

9 Notwithstanding that “[t}he law . . . recognizes that [a patentee]

may assign to another his patent, in whole or in part, and may license

others to practice his invention.” Zenith Radio Corp. v. Hazeltine

Research, Inc., supra, 395 U.S. at 135, SCM argues that a distinction

should be made between the exploitation of a patent by an inventor

and an investor. We assume, therefore, that had Chester Carlson

possessed the resources to commercialize xerography to the same

extent as did Xerox, SCM would not have challenged a refusal by the

inventor to license his patents as violative of the antitrust laws.

Investors, however, play a key role, if not an indispensable one today,

in both the inventive process and commercialization of inventions.

And it is fair to say, we think, that the contribution of the investor in

both the funding of research that leads to inventions and the promo-

tion that necessarily must follow to achieve successful commercializa-

tion is of comparable value. See generally Picard v. United Aircraft

Corp., 128 F.2d 632, 642 (2d Cir.), cert. denied, 317 U.S. 651 (1942)

(Frank, J., concurring). In either case, the ultimate intended benefi-

ciary of the patent laws—the public—is equally benefited. See gener-

ally Mannington Mills, Inc. v. Congoleum Industries, Inc., 610 F.2d

24a

If the antitrust laws were interpreted to proscribe the

natural evolution of a patent monopoly into an economic

monopoly, then Judge Newman’s concern would be well

founded. If the threat of treble damage liability for

refusing to license were imbedded in the minds of poten-

tial patent holders as a likely prospect incident to every

successful commercial exploitation of a patented inven-

tion, the efficacy of the economic incentives afforded by

our patent system might be severely diminished.

Nevertheless, it is especially clear that the economic

incentives provided by the patent laws were intended to

benefit only those persons who lawfully acquire the rights

granted under our patent system. Cf. Walker Process

Equipment, Inc. v. Food Machinery & Chemical Corp.,

382 U.S. 172 (1965 (patent obtained by fraud on Patent

Office). Where a patent in the first instance has been

lawfully acquired, a patent holder ordinarily should be

allowed to exercise his patent’s exclusionary power even

after achieving commercial success; to allow the imposi-

tion of treble damages based on what a reviewing court

might later consider, with the benefit of hindsight, to be

too much success would seriously threaten the integrity of

the patent system. Where, however, the acquisition itself

is unlawful, the subsequent exercise of the ordinarily

lawful exclusionary power inherent in the patent would be

a continuing wrong, a continuing unlawful exclusion of

potential competitors.

1059, 1070-71 (3d Cir. 1979); United States v. Parker-Rust-Proof Co.,

61 F.Supp. 805, 808 (E.D. Mich. 1945); In re Anthony, 414 F.2d 1383,

1398 (C.C.P.A. 1969); In re Herr, 377 F.2d 610, 619 (C.C.PA. 1967).

Since Xerox participated financially in both the inventive process by

funding research at Battelle and the subsequent commercialization of

xerography by bringing the first plain-paper copier to the market, we

see little reason to deny Xerox the full benefit of the patents it acquired

on this basis alone.

25a

Without passing upon the validity of Judge Newman’s

theory to preclude antitrust damage liability in all cases

where the injury is predicated upon a patent holder’s

refusal to license, we hold that where a patent has been

lawfully acquired, subsequent conduct permissible under

the patent laws cannot trigger any liability under the

antitrust laws.'° This holding, we believe, strikes an

adequate balance between the patent and antitrust laws.

Therefore, to determine whether Xerox incurred any

antitrust damage liability to SCM in 1969, our inquiry

must now shift to determining whether the acquisition of

the Carlson and Battelle patents pursuant to the 1956

agreement violated either the Sherman Act or the Clayton

Act. Because the essence of a patent is the monopoly or

exclusionary power it confers upon the holder, analyzing

the lawfulness of the acquisition of a patent necessitates

that we primarily focus upon the circumstances of the

acquiring party and the status of the relevant product and

geographic markets at the time of acquisition.

IV.

Section 2 of the Sherman Act

Turning to the facts of this case, the patents about

which we are concerned were acquired in 1956, four years

prior to the production of the 914, Xerox’s first auto-

matic plain-paper copier, and at least eight years prior to

the appearance of the relevant market and submarket. In

1956 Xerox had achieved success in the commercialization

of xerography but not in the field of automatic plain-

10 We leave for an appropriate case the resolution of the question

whether damage liability can accrue to a holder for refusing to license

patents that he subsequently abuses through pooling or otherwise.

26a

paper copying. There is evidence in the record, however,

that Xerox in 1956 valued a non-exclusive license in

xerography at $70 million and that key personnel at

Xerox believed that they already possessed the necessary

technology in 1956 to produce a plain-paper copier. Not-

withstanding their optimistic forecasts, however, the con-

fidence of the Xerox organization was still tempered by

the risks of producing a _ new, _ technologically-

sophisticated product line. Thus, in 1958 Xerox consid-

ered the possibility of having IBM manufacture and

market the 914. But before Xerox’s management made a

final decision on the matter, IBM informed them that it

was not interested in manufacturing or marketing the 914

or another model, the 813, having concluded that both

were a bad business risk. While SCM argues that IBM’s

turndown was directed exclusively at the models 914 and

813 and did not amount to a rejection of plain-paper

copying entirely, at the very least the episode demon-

strates that as of 1958 the achievement of commercial

success in plain-paper copying was not a foregone conclu-

sion.

It was also in 1956 that Xerox acquired non-exclusive

licenses from Horizons Corporation, another research

organization, covering a small number of xerographic

patents.'' Additionally, Xerox began to cultivate relation-

ships with its international family of companies in 1956.

But SCM has not argued that either the Horizons patents

or the international agreements caused it any injury.

Rather, SCM contends that these facts constitute proof of

Xerox’s willful acquisition of monopoly power over the

relevant market and submarket that came into being,

according to the jury, between eight and thirteen years

i In 1960 Horizons Corporation agreed to assign these patents to

Xerox.

27a

later. Likewise, other aspects of the 1956 agreement with

Battelle, such as the promise by Battelle to transfer to

Xerox all know-how it developed and patents it obtained

in the future were claimed to be additional evidence of

Xerox’s willful acquisition of its market dominance. But

the promise to transfer all xerographic know-how devel-

oped and patents obtained in the future was conditioned

on Xerox’s promise to contribute at least $25,000 a year

for research that would help develop the know-how and

patents. There appears to be little distinction, if any,

between patents obtained under a contract with a research

organization and patents generated internally by a com-

pany, see P. Areeda & D. Turner, Antitrust Law: An

Analysis of Antitrust Principles and Their Application

4 704e (1978), and ordinarily there is no limitation on a

company’s freedom to generate its own patents. See

generally Automatic Radio Manufacturing Co. v. Hazel-

tine Research, Inc., 339 U.S. 827, 834 (1950). The jury’s

specific finding that by 1969 Xerox had not obtained any

patents primarily for the purpose of blocking the develop-

ment and marketing of competitive products laid to rest

any suspicion that either Xerox’s internal R & D program

or its R & D work subcontracted to Battelle was driven

principally by anticompetitive animus.'? In any event,

none of Xerox’s conduct other than the acquisition of the

Carlson and Battelle patents under the 1956 agreement

caused SCM any harm. But even more important, all of

the events described occurred between eight and thirteen

years prior to the appearance of the relevant product

market and submarket defined by SCM.

12 SCM also argues that the two-year covenants not to compete

imposed by Xerox on its employees up until 1972 also evidence Xerox's

willful acquisition of monopoly power. We find this argument wholly

without merit.

28a

In scrutinizing acquisitions of patents under § 2 of the

Sherman Act, the focus should be upon the market power

that will be conferred by the patent in relation to the

market position then occupied by the acquiring party. We

agree with Professors Areeda and Turner that whether

limitations should be imposed on the patent rights of an

acquiring party should be dictated by the extent of the

power already possessed by that party in the relevant

market into which the products embodying the patented

art enter. See Areeda & Turner, supra, at { 819. There-

fore, that Xerox acquired the patents in this case four

years prior to the production of the first plain-paper

copier and at least eight years prior to the appearance of

the relevant product market and submarket over which

those patents eventually afforded it monopoly power

would seem to dispose entirely of SCM’s 1969 exclusion

claim under § 2.

SCM argues, however, that

[t]o uphold the jury’s verdicts in this case, this Court

need hold only that an agreement to purchase patents

that eliminate an existing potential for competition in

a reasonably foreseeable economic market can be

found to be unreasonable if it (a) results in the

acquisition of persistent, substantial, real-world

economic monopoly power and (b) imposes a re-

straint on competition that is greater than reasonably

necessary to induce the purchaser to develop and

market the product involved.

SCM Reply Br. at 27. SCM’s proposition is that even

prior to the commercialization of the patented invention

and prior to the appearance of the relevant market over

which Xerox eventually achieved monopoly power a § 2

violation occurred. SCM suggests that the antitrust laws

29a

impose a limitation on the extent of the rights in a patent

a purchaser may acquire, and that in some instances a

patent with its inherent exclusionary power may not be

transferred in toto. The limitation that SCM would im-

pose, however, turns not upon the market position of the

acquiring party, but rather, upon the potential for com-

mercial success a particular patent may hold. Thus, SCM

argues that a purchaser of a patent is entitled only to the

rights in a patent reasonably necessary to induce his

investment to commercialize the patent. Presumably, un-

der SCM’s proposed rule, where the commercial success

of a patented invention virtually is guaranteed, no person

other than the inventor can hold exclusive rights in the

patent, at least where it is foreseeable that the products

generated under the patent will create their own relevant

product market.

SCM contends that the test it proposes represents the

appropriate rule of reason analysis to be employed in

patent acquisition cases. By introducing the concept of

foreseeability, SCM seeks to escape an unfavorable dispo-

sition of its case that it apparently feared might be based

upon the absence of the relevant product market and

submarket at the time of the patent acquisitions in 1956.

Implicit in the jury’s findings was that it was reasonably

foreseeable in 1956 that the agreement with Battelle

would permit Xerox to obtain monopoly power in a

relevant product market.'’ While sufficient evidence was

13 This finding was implicit in the jury’s affirmative answer to question

20: “Was the probable effect of Xerox’s acquisition of patents pur-

suant to the 1956 Xerox-Battelle agreement, when the agreement was

made, substantially to lessen competition or to tend to create a

monopoly in any relevant market or sub-market that you have found

to exist?” In explaining this question, Judge Newman instructed the

jurors to determine “whether the acquisition at the time it was made

was reasonably probable to have the proscribed effect in the reasona-

bly foreseable future.”

30a

presented by Xerox to support a contrary finding, we are

unable to hold, as a matter of law, that no rational jury

could find that a reasonably foreseeable effect of the 1956

agreement was the eventual acquisition by Xerox of

monopoly power in a relevant market. But notwithstand-

ing the jury’s implicit finding, we conclude that, under

the facts presented here, the policies of the patent laws

preclude the imposition of antitrust liability.

It is undisputed that the first automatic plain-paper

copier was not produced by Xerox until four years after

the 1956 agreement was executed. Additionally, while

Xerox concedes that its plain-paper copiers eventually

formed an independent relevant product market, SCM

has not challenged on appeal the jury’s finding that this

event did not occur until some time after 1964, eight years

after the agreement. Furthermore, Xerox contributed in a

very substantial way to the development of an automatic

plain-paper copier by investing in research and develop-

ment not only after 1956 but also for almost a decade

before the agreement. Moreover, the party from whom

Xerox purchased the patent under the 1956 agreement

was not a potential competitor. We believe that, under the

circumstances presented here, to impose antitrust liability

upon Xerox would severely trample upon the incentives

provided by our patent laws and thus undermine the

entire patent system. Therefore, irrespective of the jury’s

implicit finding that Xerox’s commercial success was

reasonably foreseeable in 1956, Xerox was lawfully en-

titled to purchase the patents it did pursuant to the

agreement it made with Battelle that year.

With respect to Xerox’s subsequent unilateral refusal to

license the Carlson and Battelle patents, which we have

held were lawfully acquired, that conduct was permissible

under the patent laws and, therefore, did not give rise to

any liability under § 2.

3la

Section 1 of the Sherman Act

SCM contends that the jury implicitly concluded that

the patent acquisitions pursuant to the 1956 agreement

unreasonably restrained trade in 1956, since they had

been instructed that “if it was lawful for Xerox to acquire

the four basic Carlson patents in 1956 and the then

existing Battelle patents in 1959, then those aspects of the

1956 agreement [could not] contribute to a section 1

violation at some later time.” (J. App. 4533). While this

may be a fair inference to draw in light of the charge, we

are convinced that, as a matter of law, the 1956 agree-

ment did not unreasonably restrain trade in violation of

§ 1 at the time it was executed. As Judge Newman noted

below, the transfer of the Carlson and Battelle patents

pursuant to the 1956 agreement could not have restrained

any “competition in 1956 or 1959 because there was no

competition in any convenience-office copier or plain-pa-

per copier embodying the patented inventions” in either

of those years. 463 F.Supp. at 1004.

The gist of SCM’s § 1 argument is that absent the 1956

agreement, Battelle would have enforced the sublicensing

obligation that its prior agreements had imposed upon

Xerox, and through the sublicenses generated by that

contractual obligation there would have been competitors

in plain-paper copying, with SCM among them. Along

the lines of its § 2 argument, SCM argues that the 1956

agreement was an unreasonable restraint of trade because

it gave to Xerox absolute exclusionary power, rather than

that amount of power reasonably necessary to induce

Xerox to continue its efforts to commercialize xerog-

raphy. SCM contends that because Xerox foresaw com-

mercial success and dominance over the convenience

office copier market, the 1956 agreement which gave

Xerox the power to eliminate substantial potential com-

32a

petition was unreasonable and, therefore, illegal. Since

we have already concluded in our § 2 discussion that

under the facts presented here, the policies of the patent

laws forbid the imposition of antitrust liability irrespec-

tive of the jury’s implied finding that Xerox’s success in

plain-paper copying was foreseeable in 1956, SCM’s argu-

ment under § | along these lines must likewise fail.

While, in an economic sense, it might have been unrea-

sonable in 1964 and 1969 for Xerox unilaterally to refuse

to license for plain-paper copying use any of the xero-

graphic patents acquired pursuant to the 1956 agreement,

the lawfulness of their acquisition in 1956 rendered that

conduct, which was permitted under the patent laws,

reasonable for § 1 purposes. '*

The only continuing contractual obligation under the

1956 agreement which could be reasonably challenged

under § 1 as of 1964 or 1969 is the provision that

obligated Battelle to continue to assign to Xerox all

xerographic patents it obtained and know-how it devel-

oped. However, all of the contractual obligations betwen

Xerox and Battelle under the 1956 agreement that are

claimed by SCM to have caused it any injury were fully

performed by January 2, 1959. SCM offered no evidence

at trial that any of the patents Xerox obtained from

Battelle after January 2, 1959 caused it any harm. Since

the latter provision of the 1956 agreement does not

provide a basis for SCM to recover damages, we need not

decide its reasonableness under § 1 as of 1964 or 1969.

14 In connection with the patents assigned on January 2, 1959, the

transfer of these improvement patents on that date pursuant to the

1956 agreement was a mere formality. Under the 1956 agreement,

Xerox acquired an exclusive license to each of Battelle’s then existing

and future xerographic patents on the date the agreement was exe-

cuted. Thus Xerox had already acquired the exclusionary power

inherent in each of those patents prior to their formal assignment on

January 2, 1959.

33a

SCM argues alternatively that Xerox’s continued hold-

ing of the Carlson and Battelle patents unreasonably

restrained trade in 1969 in violation of § 1. As Judge

Newman noted below, “there is no authority for uphold-

ing damage liability under § 1 because of the subsequent

holding of a patent previously acquired.” 463 F.Supp. at

1004. And we see no reason to expand judicially the scope

of § 1 of the Sherman Act to accommodate a claim that is

already cognizable under another antitrust provision—§ 7

of the Clayton Act, see United States v. E. I. du Pont de

Nemours & Co., 353 U.S. 586 (1957) (“du Pont-GM”),

especially where the claim has been so asserted.

Section 7 of the Clayton Act

Section 7 of the Clayton Act proscribes a corporation

from acquiring the whole or any part of the assets of

another corporation where “the effect of such acquisition

may be substantially to lessen competition, or to tend to

create a monopoly [in any line of commerce],” 15 U.S.C.

§ 18 (1976). Since a patent is a form of property, see

generally Transparent-Wrap Machine Corp. v. Stokes &

Smith Co., 329 U.S. 637, 643 (1947), and thus an asset,

there seems little reason to exempt patent acquisitions

from scrutiny under this provision. See United States v.

Lever Brothers Co., 216 F.Supp. 887, 889 (S.D.N.Y.

1963); see generally L. Sullivan, Handbook of the Law of

Antitrust, § 180 (1977); 16a J. von Kalinowski, Business

Organizations: Antitrust Laws and Trade Regulation

§ 16.05 (1980); Kessler & Stern, Competition, Contract,

and Vertical Integration, 69 Yale L. J. 1, 75-78 (1959).

Section 7 principally was designed to curtail the anti-

competitive consequences of corporate acquisitions in

their “incipiency.” Brown Shoe Co. v. United States, 370

U.S. 294, 317 (1962). Thus, the analysis ordinarily em-

34a

ployed in determining the lawfulness of a corporate acquisi-

tion under § 7 is prospective in nature. The jury found that

the probable effect of the 1956 Xerox-Battelle agreement

was substantially to lessen competition or to tend to create a

monopoly in the relevant product market and submarket

that appeared between eight and thirteen years later. The

jury additionally found that, as of 1964 and 1969, the prob-

able effect of Xerox’s continued holding of patents ac-

quired pursuant to the 1956 Xerox-Battelle agreement was

substantially to lessen competition or to tend to create a

monopoly. We conclude that neither of these findings can

stand as a matter of law.

While the Supreme Court in Brown Shoe Co, v. United

States, supra, 370 U.S. at 323, stated that the language

contained in § 7 is indicative that Congress’ “concern was

with probabilities, not certainties,” the speculative aspect

of this antitrust law was intended to allow courts to

appreciate immediately the potential consequences that a

particular acquisition might have upon an existing line of

commerce. Thus in Brown Shoe, the Supreme Court

stated:

Because § 7 of the Clayton Act prohibits any merger

which may substantially lessen competition “in any

line of commerce,” (emphasis supplied) it is neces-

sary to examine the effects of a merger in each such

economically significant submarket to determine if

there is a reasonable probability that the merger will

substantially lessen competition.

370 U.S. at 325. The existing market provides the frame-

work in which the probability and extent of an adverse

impact upon competition may be measured. In the case at

bar it would have been impossible to examine the effects

35a

of the Xerox-Battelle agreement upon the relevant prod-

uct market and submarket in 1956 because those markets

did not come into being until sometime between 1964 and

1969. The jury was instructed that it should include in its

considerations whether the appearance of the relevant

market and submarket and Xerox’s domination of those

markets was reasonably foreseeable in 1956. (J. App.

4551-54).

Judge Newman concisely stated below that “[s]Jection 7

is concerned with undue concentrations of power and the

anti-competitive effects of permitting one entity with

market power to strengthen its position by acquisition.”

463 F.Supp. at 1001-02. Where, as here, it is conceded

that the relevant product market and submarket did not

exist until eight years following the patent acquisitions

and that Xerox possessed no power whatsoever in even

the inchoate market and submarket until 1960 when it

introduced its 914 copier, as a matter of law the 1956

agreement did not violate § 7 at the time it was made.

Finally, our decision regarding SCM’s foreseeability argu-

ment under §§ | and 2 of the Sherman Act disposes of its

argument propounded under § 7 along those lines.

SCM argues alternatively that the Supreme Court’s

decisions in du Pont-GM, supra, and United States v.

ITT Continental Baking Co., 420 U.S. 223 (1975), require

that we affirm the jury’s second finding under § 7 that

Xerox’s continued “holding” of the patents it obtained

under the Xerox-Battelle agreement in 1956 violated § 7

as of 1969. In du Pont-GM, the government commenced

its action approximately thirty years after du Pont had

purchased a twenty-three percent stock interest in General

Motors Corporation, and alleged that du Pont had used

its stock ownership to attain a “commanding position as

36a

General Motors’ supplier of automotive finishes and

fabrics,” 353 U.S. at 588-89. There, the Court held that

any acquisition by one corporation of all or any part

of the stock of another corporation, competitor or

not, is within the reach of the section whenever the

reasonable likelihood appears that the acquisition

will result in a restraint of commerce or in the

creation of a monopoly in any line of commerce.

353 U.S. at 592 (emphasis added). Subsequently, in /77

Continental Baking, the Court reaffirmed, albeit in dic-

tum, its holding in du Pont-GM that the term acquisition

as it is employed in § 7 comprehends both the initial

“acquiring” and subsequent “retaining” of the stock of

another corporation. 420 U.S. at 241-42. Relying on these

cases, SCM would have us hold that Xerox’s acquisition

of the Carlson and Battelle patents in 1956 became

actionable under § 7 as soon as the monopoly afforded by

the patents burgeoned into an economic monopoly. What-

ever the meaning that may be ascribed to § 7 in other

contexts, the patent laws circumscribe the scope of the

provision here. Where a corporation’s acquisition of a

patent is not violative of § 7, as was the case here, its

subsequent holding of the patent cannot later be deemed

violative of this section. Where a company has acquired

patents lawfully, it must be entitled to hold them free

from the threat of antitrust liability for the seventeen

years that the patent laws provide. To hold otherwise

would unduly trespass upon the policies that underlie the

patent law system. The restraint placed upon competition

is temporally limited by the term of the patents, and

must, in deference to the patent system, be tolerated

throughout the duration of the patent grants.

37a

The MUP Claim

The jury determined that the Machine Utilization Plan

implemented by Xerox in 1968 coerced some of Xerox’s

high-volume machine customers to take Xerox’s low-vol-

ume machines and that the effect of MUP was to tend to

create a monopoly or to lessen substantially competition

in a relevant market or submarket. These findings sup-

ported SCM’s contention that MUP constituted an illegal

tying arrangement in violation of § 3 of the Clayton Act,

15 U.S.C. § 14 (1976). The jury additionally concluded

that MUP was utilized by Xerox to foreclose competition

or to gain a substantial competitive advantage. This

finding translated into a § 2 violation, since the jury also

determined that Xerox possessed monopoly power in 1969.

See generally United States v. Griffith, supra, 334 U.S. at

107. Judge Newman ruled, however, that notwith-

standing the jury’s findings concerning the substantive

aspects of SCM’s MUP claim, SCM had failed to demon-

strate a rational, causal connection between the profits

lost by SCM and MUP.

In Bigelow v. RKO Radio Pictures, Inc., 327 U.S. 251,

264 (1946), the Supreme Court set forth the standard to

be satisfied to sustain an award of treble damages in a

private antitrust suit:

[I]n the absence of more precise proof, the jury [can]

conclude as a matter of just and reasonable inference

from the proof of defendants’ wrongful acts and

their tendency to injure plaintiffs’ business, and

from the evidence of the decline in prices, profits and

values, not shown to be attributable to other causes,

that defendants’ wrongful acts had caused damage to

the plaintiffs.

38a

We agree that a liberal rule of damages must be applied in

antitrust cases both to encourage private enforcement of

the antitrust laws and to insure that the defendant bears

“the risk of the uncertainty which his own wrong has

created.” Jd. at 265; see Jack Kahn Music Co. v. Baldwin

Piano & Organ Co., 604 F.2d 755, 763 (2d Cir. 1979). But

the Bigelow Court carefully pointed out that “even where

the defendant by his own wrong has prevented a more

precise computation, the jury may not render a verdict

based on speculation or guesswork.” Bigelow v. RKO

Radio Pictures, Inc., supra, 327 U.S. at 264. We are of

the opinion that even under the liberal Bigelow rule, SCM

failed to carry its burden.

SCM calculated its damages caused by MUP based on

the cancellation rates of Xerox’s low-volume copiers

before and after the MUP marketing program was imple-

mented. SCM’s theory is that if MUP had the effect of

decreasing the cancellation rates of its low-volume cop-

iers, then it can be inferred that MUP coerced some

customers into retaining unwanted Xerox low-volume

copiers instead of using low-volume coated-paper copiers

manufactured by Xerox’s competitors. SCM offered evi-

dence of the percentage of Xerox low-volume machine

customers who cancelled and were acquired by SCM prior

to MUP and the drop in the overall Xerox low-volume

machine cancellation rate and the concomitant loss of

dissatisfied Xerox customers after MUP. SCM contended

that it would have received the same share of the addi-

tional cancellations that it received of actual cancellations

after MUP. Xerox, however, revealed a gaping hole in

SCM’s damage theory: the cancellation rates of three out

of four of Xerox’s low-volume machines actually in-

creased following MUP. Additionally, with respect to the

only Xerox low-volume machine whose cancellation rate

39a

actually fell following MUP, the 813, Xerox pointed out

that SCM calculated its lost placements on the basis of

the entire 813 population rather than on the substantially

smaller population of 813s on MUP. While the latter

deficiency would merely require that the damages be

recalculated on remand, the insufficient showing of

causality between MUP and the decline in 813 cancel-

lations leads us to affirm Judge Newman’s conclusion

below. While an antitrust plaintiff may, in a proper case,

recover damages based upon evidence of lost profits “not

shown to be attributable to other causes,” Bigelow v.

RKO Radio Pictures, Inc., supra, 327 U.S. at 264, the

plaintiff must support by more than mere speculation its

allegation of causality between the defendant’s acts and

the injury it incurred. SCM’s own expert witness con-

ceded at trial that he could not explain the fact that the

cancellation rates of three out of four of Xerox’s low-vol-

ume machines increased following MUP. In light of these

facts we agree with Judge Newman’s decision that it

would be irrational to attribute the decline in the cancel-

lation rate of the 813 to MUP.

Conclusion

The controlling question of law certified by Judge

Newman below and accepted by this Court for interlocu-

tory review concerning SCM’s 1969 exclusion claim is

answered in the negative. Based on the evidence presented

we are convinced that none of Xerox’s patent-related

conduct contributed to any antitrust violation and that,

therefore, SCM is not entitled to recover any monetary

damages in connection with that claim.

With respect to SCM’s MUP claim, we affirm Judge

Newman’s decision denying damage recovery on the

40a

ground that insufficient evidence was offered by SCM to

support the jury’s finding that the lost profits claimed by

SCM were caused by MUP.

This action is remanded to the district court for further

proceedings consistent with this opinion.

>

WATERMAN, Circuit Judge:

I concur in the result.

Appendin B

Opinion of the District Court

4la

SCM CORPORATION

Vv.

XEROX CORPORATION.

Civ. No. 15807.

United States District Court,

D. Connecticut.

Dec. 29, 1978.

MEMORANDUM OF DECISION

[463 F. Supp. 983]

NEWMAN, District Judge.

[985] This case presents important issues concerning the

relationship between the patent laws and the antitrust laws.

The issues arise in the procedural context of a private treble

damage action brought pursuant to § 4 of the Clayton Act, 15

U.S.C. § 15, and tried to a jury. The factual context is the

manufacturing and marketing of office photocopy machines—

machines capable of automatically creating copies of an origi-

nal document.

Plaintiff is SCM Corporation,' a conglomerate with annual

revenues in excess of $1 billion. During the 1960’s SCM was

among the world’s leading producers of coated paper copiers—

machines capable of automatically creating copies of an origi-

nal document on specially treated paper coated with zinc

oxide. In the mid 1970’s SCM marketed a plain paper copier,

the 6740, which it purchased from the Van Dyk Corporation,

I “SCM” is derived from the initials of the Smith-Corona Company,

manufacturer of typewriters, and the Marchant Company, manufac-

turer of calculators, who merged to form the plaintiff corporation.

42a

and currently markets two models of a plain paper copier

manufactured by a Japanese company.

Defendant is Xerox Corporation,’ a business machines com-

pany with annual revenues in excess of $4 billion. In 1960

Xerox brought to market the world’s first automatic plain

paper copier, the Xerox 914. For the next ten years Xerox and

its family of companies were the world’s only producers of

plain paper copiers. While a competitive plain paper copier

was introduced by IBM in 1970 and by numerous manufac-

turers thereafter, Xerox continues today to be the world leader

in plain paper copiers.

The complaint, filed July 31, 1973, alleged that Xerox,

acting unilaterally and in concert with other companies, ex-

cluded SCM from the field of plain paper copying, causing

damages claimed at trial to exceed $500 million. The complaint

alleged violations of §§ 1 and 2 of the Sherman Act, 15 U.S.C.

§§ 1 and 2, and § 7 of the Clayton Act, 15 U.S.C. § 18. An

amended complaint added allegations of injury to SCM’s

copier business by Xerox marketing practices in violation of

§ 2 of the Sherman Act and § 3 of the Clayton Act, 15 U.S.C.

§ 14. In addition to trebled damages, far-reaching equitable

relief was sought.’ A preliminary [986] injunction was sought

and denied. Pre-trial Ruling No. 6, aff’d, SCM Corp. v. Xerox

Corp., 507 F.2d 358 (2d Cir. 1974).

After extensive pre-trial preparations, see SCM Corp. v.

Xerox Corp., 77 F.R.D. 10 (D.Conn.1977), jury trial* began on

2 “Xerox” is derived from the word “xerography”—dry writing—an

invented name for the process of reproducing images by an electropho-

tographic process.

3 Other issues raised by the pleadings concerned an SCM claim of

invalidity of one Xerox patent, and Xerox claims of patent infringe-

ment by SCM. These patent validity and infringement issues have been

severed. For purposes of all claims put to the jury, SCM assumed the

validity of every Xerox patent.

4 The jury, requested by Xerox, was empaneled under an agreed upon

procedure whereby 14 persons were selected, none was designated as

43a

June 20, 1977. Fourteen months later, on August 16, 1978, the

jury was discharged after returning the last of 54 verdicts.

Evidence was presented during 215 days, summations con-

sumed 412 days, and the jury deliberated for 38 days. The trial

transcript totals 46,802 pages.

I. Basic Claims and Verdicts

SCM Damage Claims.

SCM presented damage claims in five broad categories:

excluding SCM from plain paper copying beginning in 1964;

excluding SCM from plain paper copying beginning in 1969;

denying SCM the opportunity to market in the United States

the Fuji-Xerox 2200 copier manufactured in Japan; impairing

SCM’s marketing of coated paper copiers by use of two pricing

plans known as MUP and XCP; and impairing SCM’s market-

ing of 6740 plain paper copiers by various practices.

The 1964 and 1969 exclusion claims were the heart of SCM’s

case. SCM alleged, alternatively, that beginning in 1964 or 1969

and continuing until the present, Xerox monopolized the plain

paper copier industry and excluded SCM from entering the

field. SCM sought the damages it would have avoided if Xerox

had not refused SCM’s requests in 1964 and 1969 for plain

paper copier patent licenses. The 1964 and 1969 exclusion

claims each contained three elements of damages: (a) the

financial benefits SCM would have achieved, which included

net profits through 1976 and net going concern value as of the

end of 1976; (b) the actual losses SCM incurred in the place-

ment of coated paper copiers; and (c) the actual losses SCM

an alternate, and all remaining at the conclusion of the trial were

permitted to deliberate provided at least six remained. Attrition re-

duced the final jury to nine members.

For an interesting analysis of the composition of the jury and how

the demographic characteristics of the final jury was shaped by the

selection process, see Comment, “Protracted Commercial Litigation

and the Seventh Amendment,” 10 Conn.L.Rev. 775 (1978).

44a

incurred in the placement of the 6740 plain paper copiers. It

was SCM’s theory that had it not been excluded from entering

into plain paper copying in 1964 and 1969, it would not only

have made money, but would have avoided the losses it

suffered in its coated paper copier business and in the place-

ment of 6740's.

The presentation of both a 1964 and a 1969 exclusion claim

stemmed from a dispute concerning application of the statute

of limitations. SCM initially sought patent licenses from Xerox

in 1964° and annually thereafter at least through 1969. The

complaint was filed July 31, 1973. Normally the applicable

four-year statute of limitations would apply to bar any cause of

action accruing prior to July 31, 1969. 15 U.S.C. § 1Sb.

However, SCM alleged, and Xerox did not dispute, that the

limitations period was extended back to January 16, 1969,

because (1) on that date the Federal Trade Commission filed a

complaint against Xerox alleging monopolization of the plain

paper copying field, and (2) the institution of proceedings by

the United States suspends the running of the statute of

limitations “in respect of every private right of action . .

based in whole or in part on any matter complained of in said

proceeding. . . .” 15 U.S.C. § 16(b). Actions initiated by the

FTC toll the four-year limitations period. Minnesota Mining &

Manufacturing Co. v. New Jersey, 381 U.S. 311, 85 S.Ct.

1473, 14 L.Ed.2d 405 (1965). Xerox also raised no [987] issue

concerning the first two weeks of January, 1969; so the parties

were in agreement that SCM’s 1973 complaint was timely as to

causes of action accruing on or after January 1, 1969.° The

5 There was a substantial dispute as to whether the SCM license

request in 1964 was serious and whether SCM then had the intention,

preparedness, and capability to enter the plain paper copying field, an

issue ultimately resolved against SCM by the jury (Question 22). But

there was no dispute that a license request was made in 1964,

6 Though Xerox agreed the complaint was timely with respect to the

1969 exclusion claim as against the defense of limitations, it presented

a further defense that SCM’s failure to sue at an earlier time rendered

all exclusion damages barred under the doctrine of avoidable conse-

quences. See note 16, infra.

45a

1969 exclusion claim therefore sought damages SCM alleged it

had suffered by being denied patent licenses on or about

January 1, 1969.

As an alternative to the 1969 exclusion claim, SCM pre-

sented a 1964 exclusion claim for damages allegedly suffered

by being denied patent licenses on or about January |, 1964.

SCM contended that the four-year limitations period, as ex-

tended back to January 16, 1969, by the FTC complaint, did

not bar this claim because, under the principles of Zenith

Radio Corp. v. Hazeltine Research, Inc., 401 U.S. 321, 91

S.Ct. 1247, 28 L.Ed.2d 552 (1971), the damages flowing from

the 1964 license denial were not ascertainable until after Janu-

ary 16, 1969, and the cause of action based on the 1964 license

denial had therefore not accrued until after January 16, 1969.’

With respect to both the 1964 and 1969 exclusion claims,

SCM estimated its lost profits by presenting elaborate

economic models as to what would have happened if it had

secured from Xerox plain paper copier licenses on or about

January | of 1964 and 1969." SCM estimated the types of

7 SCM also contended that the tolling provisions of 15 U.S.C. § 16(b)

extended the limitations period back to 1965, when the FTC began its

investigation of Xerox. The Court concluded that the filing of the FTC

complaint was the earliest relevant date for purposes of § 16(b). C/.

Greyhound Corp. v. Mt. Hood Stages, Inc., 437 U.S. 322, 98 S.Ct.

2370, 57 L.Ed.2d 239 (1978).

8 SCM also contended that it was not limited to exclusion claims

measured from either January |, 1964, or January 1, 1969, but could

also seek damages starting a: any intermediate point that the jury

found warranted by the evidence. This contention became significant

when the jury rejected the 1964 claim, leaving only the 1969 claim in

issue. The Court ruled that SCM had given the jury evidence of

damages flowing from the 1964 license denial and the 1969 license

denial, and had failed to present any evidence from which the jury

could reasonably estimate what the damages would have been had

SCM obtained patent licenses at some intermediate point. There was

no data or opinion evidence that would permit a pro rata award of

damages for whatever portion of the 1964 exclusion claim the jury

found to be established. SCM’s estimates of what would have occurred

(footnote continued on next page)

46a

machines it would have manufactured, the revenues it would

have realized, and the costs it would have incurred. Since the

1964 exclusion claim estimated placements and profits over a

longer period of time than the period estimated for the 1969

claim, the 1964 damage claim was considerably higher. SCM

sought $507 million for the 1964 exclusion claim and $100

million for the 1969 exclusion claim. SCM also sought $12

million for the Fuji-Xerox 2200 claim, $15 million for the

MUP and XCP marketing claims, and $4 million for the 6740

marketing claim. SCM also sought trebling of all sums recov-

ered.

Structure of the Trial.

The presentation of evidence was divided into three stages.

The first stage, which consumed the bulk of the trial, con-

cerned all issues of antitrust violation and the lost profits

component of the 1964 and 1969 exclusion damage claims.’

if it had obtained licenses in 1964 or 1969 differed in fundamental

respects. SCM estimated the production of entirely different machines,

different market shares, different prices, and different costs. Whether

or not the 1964 and 1969 damage estimates were sufficiently non-spec-

ulative to permit a damage award, any estimate of damages for a

period beginning at an intermediate point would have been wholly

speculative,

9 The Court permitted evidence of SCM’s claimed lost profits to be

presented in what was generally the liability phase of the trial because

of Xerox's contention concerning SCM’s intention to enter plain paper

copying. Xerox maintained that SCM did not intend to enter plain

paper copying in either 1964 or 1969 and offered to support this

contention with evidence that if SCM had entered the field at either

date, SCM would have suffered losses. Since the prospect of losses was

relevant in dete: mining whether SCM had the requisite intent, the jury,

considering the existence of intent, was entitled to hear the parties’

conflicting claims as to whether SCM would have made profits or

suffered losses. All the evidence available at the end of 1976 and

offered to show whether entry in 1964 or 1969 would actually have

produced profits would not have been available in 1964 or 1969 to

estimate prospectively the likelihood of profits. However, there was

substantial overlap between the bases for estimates available to be

47a

The second [988] stage, consuming three days of evidence,

concerned the actual loss components (for both coated and

plain paper) of the 1969 exclusion damage claim,'’ plus the

damage claims based on marketing practices.'' The third stage,

requiring only one day of evidence, concerned the net going

concern value component of the 1969 exclusion damage

claim.'?

The Court elected to submit to the jury a large number of

interrogatories. This was done, over the plaintiff’s objection,

for two reasons. First, the sheer volume and complexity of the

10

12

made prospectively in 1964 and 1969 and for estimates to be made

retrospectively in 1976, Therefore, Xerox was given an opportunity to

prove that losses would have occurred, so that it could contend that the

prospect of such losses would have deterred SCM in 1969 from

entering plain paper copying if licenses were available.

SCM claimed $40.5 million for actual losses.

Since the jury at the end of the first stage rejected SCM's claim

concerning the Fuji-Xerox 2200 and the 6740 marketing claim, no

evidence was presented concerning the amount of damages on these

claims. The jury's findings in favor of SCM concerning the MUP and

XCP pricing claims led to the presentation of damage evidence on

these claims. In addition, the Court concluded, contrary to the posi-

tion taken when the first stage was concluded, to permit the jury to

consider evidence of the component of SCM’s 1969 exclusion claim

concerning actual losses in the placement of 6740's, This is not the

6740 marketing claim rejected by the jury in the first stage. That claim

concerned Xerox practices alleged to impair SCM’s ability to place

6740's. The 6740 actual loss claim was that if SCM had been granted

plain paper copier patent licenses in 1969, it would not have embarked

on the 6740 program at all in the 1970's and thereby avoided all the

actual losses it sustained in that venture.

SCM claimed $48.2 million for loss of net going concern value. The

Court separated evidence of the net going concern value damages into

a third stage of the trial to avoid the risk of prejudice to Xerox when

the jury considered the amount of lost profits under the 1969 exclusion

claim, Since the net going concern value claim was of exceedingly

doubtful validity, it seemed advisable to avoid the risk that the jury

might assess that claim and the lost profits claim together and reach a

compromise that might be based on an invalid theory.

48a

evidence necessitated focusing the jury’s attention on specific

issues to be sure that orderly decision-making occurred. Sec-

ond, the use of numerous interrogatories seemed to offer some

prospect of minimizing the risk of retrial. That objective

assumed special importance in this case because of the extraor-

dinary length of the trial and the presence of numerous novel

or at least unsettled issues of law.'’ Maximizing jury decision-

making remained a principal objective of the Court throughout

the trial in order to provide opportunity for particularized

appellate review. The interrogatories answered by the jury are

set forth in full in Appendix A. Since the 1964 and 1969

exclusion claims raised numerous pairs of identical issues,

differing only as to years, many of the questions concerning

the 1964 claim were repeated for the 1969 claim, and given the

same number but with the addition of an “a.”

As with the evidence, the jury’s decision-making was divided

into stages, but, for reasons detailed in the margin'’ the

13. See Vandercook & Son, Inc. v. Thorpe, 344 F.2d 930, 931 n. 2 (Sth

Cir. 1965), indicating “the desirability of using special interrogatories

under Fed.R.Civ.P. 49a) with a general charge where distinctive, or

doubtful (or both), theories are at issue, or where the law is in a state

of flux.” See generally, Brown, “Federal Special Verdicts: The Doubt

Eliminator,” 44 F.R.D. 338 (1967),

14s Three differences should be noted. First, though the evidence con-

cerning the amount of lost profits in the 1969 exclusion claim was

presented in the first stage, the decision-making as to quantification of

this component of the 1969 exclusion claim occurred at the end of the

second stage. (Questions 50 and 51), See footnote 9, supra. Second,

though evidence of proximate cause was presented in the first stage,

decision-making on several proximate cause issues was deferred until

the second stage so that the jury would have evidence of the amount of

damage when deciding whether any damages were proximately caused

by wrongful conduct. Proximate cause issues submitted to the jury in

the second stage concerned the MUP and XCP pricing plans (Ques-

tions 52, 54, and 57) ard the 6740 actual loss component of the 1969

exclusion claim (Question 59). Third, though evidence concerning the

XCP pricing plan was presented in the first stage, the violation

questions submitted to the jury at the end of the first stage concerning

the pricing plan issues (Questions 43-47) and the jury’s responses left

49a

divi-[989]sion of jury decision-making differed slightly from

the division of evidence. Initially 76 questions were submitted

to the jury at the conclusion of the first stage of evidence. The

jury was instructed first to answer the four questions concern-

ing the relevant product markets (Questions 1, la, 2, and 2a)

and report their verdicts on these issues before proceeding

further. The jury’s verdicts on the product market issues,

agreeing with SCM’s contentions as of 1969, but not as of

1964, prompted the Court to withdraw from the jury’s consid-

eration nine questions dealing with the 1964 exclusion claim.

Since some of the remaining questions were to be answered

only if a “yes” answer were given to preceding questions, the

jury answered 44 questions at the end of the first stage. One

aspect of the jury’s responses, discussed at pages 1009-1010,

infra, prompted the Court to submit two additional questions

(Questions 24a-1 and 27a-1). In the second stage, the jury was

given 11 questions, concerning some issues of proximate cause

and quantification of damages. Because of some negative

answers, the jury answered seven questions of this group. In

the third stage only a single question was asked and answered.

This concerned quantification of the net going concern value

component of the 1969 exclusion claim.

Jury’s Verdicts on SCM’s Damage Claims.

The jury’s verdicts were in favor of SCM on some parts of

two of the five damage claims, but also in favor of Xerox on

one of its defense contentions. As to the 1964 exclusion claim,

the jury rejected SCM’s contentions concerning the relevant

market or sub-market as of 1964. (Questions | and 2). SCM

had contended that there existed by 1964 a relevant market

consisting of “convenience office copiers” using both plain and

coated paper and a relevant sub-market consisting of “conven-

ience office copiers” using only plain paper. “Convenience

in doubt the jury’s view of the XCP plan. Therefore, a separate

question as to whether the XCP plan was a law violation was

submitted at the end of the second stage (Question 56).

50a

office copiers” meant copying machines suitable for automatic

use in offices but not including spirit duplicators, mimeograph

machines, or offset machines. Xerox defined the relevant

market to include spirit, mimeo, and offset, with offset in-

cluded to the extent that the machines were used for run

lengths of less than 200 copies from an original.

Despite the jury’s rejection of SCM’s market definitions as

of 1964, the jury was asked several questions concerning other

aspects of the 1964 claim.'* The jury concluded that SCM had

not proved that in 1964 it [990] had the intention, prepared-

ness, and capability to enter into plain paper copying. (Ques-

15 The substantive questions concerning some aspects of the 1964

exclusion claim were submitted to the jury, notwithstanding the jury’s

rejection of SCM’s 1964 relevant market contentions, for two reasons.

First, additional fact-finding by the jury offered the prospect of

determining whether necessary elements of the 1964 exclusion claim

were established wholly apart from the relevant market contentions.

As it happened, the negative answer concerning SCM’s intention,

preparedness, and capability to enter plain paper copying in 1964

eliminated the 1964 claim, regardless of the relevant market issues and

regardless of any SCM contention concerning the correctness of the

charge on issues of violation. Second, this course created the opportu-

nity to secure add

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.